Promotions

• Kelly Covert: Associate Professor of Pharmacy Practice, East Tennessee State University Bill Gatton College of Pharmacy.
• Josh Gaborcik: Director, Ohio State Pharmacy Residency Programs, The Ohio State University Wexner Medical Center & College of Pharmacy.

 

Awards

• Paul Boylan:

2022 Teaching and Mentoring Award, ACCP Education and Training PRN.

2022 Outstanding Educator, OUHSC College of Pharmacy – PCAS Department.

2022 ACCP Virtual Poster Symposium Top Poster, ACCP Education and Training PRN.

2022 ACCP Virtual Poster Symposium Top Poster, ACCP Adult Medicine PRN.

• Corey Guidry:

AMED PRN Practitioner Training and Travel Award, ACCP AMED PRN.

Outstanding Adult Medicine Preceptor, OU College of Pharmacy.

• Ashley Otto: New Investigator Award, Mayo Midwest Pharmacy Research Committee, Mayo Clinic.
• Jon P. Wietholter: Member of the Fulbright Specialist Roster (2022–2025) for International Clinical Pharmacy and Education Development, U.S. Department of State Bureau of Educational and Cultural Affairs.

 

Publications

• Adams KK, et al. Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis. Addict Sci Clin Pract 2022;17(55).
• Adams KK, Shah S. Large healthcare system evaluation of postoperative moxifloxacin ophthalmic solution cross-reactivity. J Cataract Refract Surg 2022;48:1347-8.
• Cluck D, Covert K, Wagner J, et al. A primer on post-COVID-19 conditions and implications for clinical pharmacists. J Am Coll Clin Pharm 2022;5:716-24.
• Epperson T, Bennett K, Kupiec K, et al. Impact of a pharmacist-managed outpatient parenteral antimicrobial therapy (OPAT) service on cost savings and clinical outcomes at an academic medical center. Antimicrob Steward Healthc Epidemiol 2023;3:e15.
• Flurie RW. Disorders of potassium and magnesium homeostasis. In: DiPiro JT, et al., eds. Pharmacotherapy: A Pathophysiologic Approach, 12th ed. McGraw-Hill, 2022.
• Flurie RW, Hylton Gravatt LA, Radwan RM, et al. Residents’ assessment of mentoring received on lecture performance in a teaching and learning curriculum program. Curr Pharm Teach Learn 2022;14:1463-70.
• Flurie RW, Szwak J, Beck T, Herink MC, Wdowiarz K, Hong L, Hellwig T, Nemecek B, et al. Internal medicine pharmacy residency programs: residents’ pursuit of post-residency positions and job market perceptions. J Am Coll Clin Pharm 2023;6:103-10.
• Gibson CM, Flurie RW. Nonsteroidal MRAs: will finerenone take the throne? Cardiology Today. November 2022.
• Fritz MK, Mangino AA, Hunt TV, et al. Clinical outcomes of oral zinc therapy in hepatic encephalopathy treatment. Ann Pharmacother 2022 Nov 11. [Epub ahead of print]
• Gibson CM, Gordon S, White A, et al. An assessment of patient experiences as teachers of cultural sensitivity in an interprofessional setting. Curr Pharm Teach Learn 2022;14:1032-9.
• Gibson CM, Larson S, Behnen EM, et al. Feeding the soul: the impact of community circles on the AACP Women Faculty SIG. Am J Pharm Educ 2022;86:Article 8927.
• Drame I, Gibson CM, Nonyel NP, et al. Toward a programmatic approach for health disparities and cultural competency training: curriculum and co-curriculum. Am J Pharm Educ 2022;86:Article 8631.
• Stone KH, Reynolds K, Davis S, Van Tassell B, Gibson CM. Comparison of new-onset post-operative atrial fibrillation between patients receiving carvedilol vs. metoprolol after coronary artery bypass graft surgery. Gen Thorac Cardiovasc Surg 2022 Sep 30. [Epub ahead of print]
• Guidry CM, Jackson BT, Hawkins WA. Layered learning: eight precepting strategies for the new attending pharmacist. Am J Health Syst Pharm 2022. [Epub ahead of print]
• Chun H, Covvey JC, Zimmerman DE, Nemecek BD. Initiation of oral antihypertensives in hospitalized patients with hypertensive urgency: a descriptive study. Am J Health Syst Pharm 2022 Dec 2. [Epub ahead of print]
• Thurber KM, Otto AO, Stricker SL. Proton pump inhibitors: understanding the associated risks and benefits of long-term use. Am J Health Syst Pharm 2023 Jan 11. [Epub ahead of print]
• Zeuli JD, Rivera CG, Smith BL, Otto A, et al. Cabotegravir: a novel HIV integrase inhibitor combined with rilpivirine as the first long-acting injectable program for the treatment of HIV infection. Drugs Today (Barc) 2022;58:555-76.
• Soric MM. Study designs: design and application. In: Bernhardt MB, Blackmer A, Cho HJ, et al., eds. Updates in Therapeutics^®: Pediatric Pharmacy Preparatory Review and Recertification Course, 2022 ed. American College of Clinical Pharmacy, 2022:827-56.
• Soric MM. Overview of the hematologic system. In: Stuhan MA, ed. Understanding Pharmacology for Pharmacy Technicians, 2nd ed. American Society of Health-System Pharmacists, 2023:537-46.
• Soric MM. Overview of the cardiovascular and renal systems. In: Stuhan MA, ed. Understanding Pharmacology for Pharmacy Technicians, 2nd ed. American Society of Health-System Pharmacists, 2023:281-96.
• Soric MM. Hypertension. In: Stuhan MA, ed. Understanding Pharmacology for Pharmacy Technicians, 2nd ed. American Society of Health-System Pharmacists, 2023:297-316.
• Soric MM. Heart disease. In: Stuhan MA, ed. Understanding Pharmacology for Pharmacy Technicians, 2nd ed. American Society of Health-System Pharmacists, 2023:317-52.
• Soric MM. Hyperlipidemia. In: Stuhan MA, ed. Understanding Pharmacology for Pharmacy Technicians, 2nd ed. American Society of Health-System Pharmacists, 2023:353-65.
• Okoroike H, Patel S, Simone P, Lavelle R, Szwak J. Impact of inpatient initiation of sodium-glucose cotransporter-2 inhibitors on prescription rates in patients with heart failure with reduced ejection fraction. Am J Cardiol 2023;186:150-5.
• Molleti RR, Bidell MR, Tatara AW. Fidaxomicin-associated hypersensitivity reactions: report of a morbilliform drug eruption. J Pharm Pract 2022 Sep 16. [Epub ahead of print]
• Ho TT, Noble M, Tran BA, et al. Clinical impact of the CYP2C19 gene on diazepam for the management of alcohol withdrawal syndrome. J Pers Med 2023;13:285.
• Wietholter JP. Chapter 66: Primary open-angle glaucoma. In: Pharmacotherapy Principles & Practice Study Guide: A Case-Based Care Plan Approach, 6th ed. McGraw-Hill Medical, 2023.

 

Presentations

• Sarah Anderson

Cardiovascular disease risk management for people living with mental illness. Presented at: CPS Winter Meeting; January 2023; Beaver Creek, CO.

Getting to the heart of the matter: race-based medicine in cardiovascular disease. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

Illuminating the patient perspective: what healthcare professionals should know about living with nontuberculous mycobacterial lung disease. Presented at: CHEST 2022 Meeting; October 2022; Nashville, TN.

• Peter Boylan

Updates in allergic rhinitis and conjunctivitis: when to recommend the new Rx-to-OTC switches. Presented at: Walter P. Scheffe Continuing Pharmaceutical Education Series; October 2022; Oklahoma City, OK.

Building a better tomorrow with your colleges of pharmacy. Presented at: National Association of Boards of Pharmacy Districts 6, 7, 8 Meeting; August 2022; Oklahoma City, OK.

• Cait Gibson: Updates in Cardiology: Last-Chance Pharmacotherapy Review Webinar. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; September 2022; virtual.
• Corey Guidry: Old DOACs, new tricks. Presented at: Oklahoma Society of Health-System Pharmacists 2022 Fall Meeting; September 2022; Broken Arrow, OK.
• Thaddeus McGiness: IV iron replacement therapy to mitigate the burden of IDA: updates for health system pharmacists. Presented at: ASHP Midyear Clinical Meeting; December 2022; Las Vegas, NV.
• Jennifer Szwak: Current state of high-value pharmacy enterprise implementation. Presented at: Vizient Connections Summit; September 2022; Las Vegas, NV.
• Jon P. Wietholter: ACCP Career Path Roundtable Session: Adult medicine acute care practice facilitator. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

 

New ACCP Fellows

• Jennifer Austin Szwak

 

Other Notable Achievements

• Sarah Anderson: Use of a crowdsourced needs assessment to create an innovative microlearning program to address healthcare professionals’ misunderstandings in applying hepatitis B virus treatment guidelines. Poster named 1 of 5 finalists for Best Poster Award at the Alliance Annual Conference; February 2023; Washington, DC.
• Nicole Metzger: Evaluation of prior authorization approval and patient assistance program acceptance between pharmacy trainees and clinical pharmacy specialists. Poster awarded third place by the ACCP Adult Medicine PRN Walk-Rounds Committee at the ACCP Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

 

 

 

Promotions

• Rhianna Fink: Associate Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO.
• Andrew Hwang: Associate Professor, Massachusetts College of Pharmacy and Health Sciences, Boston, MA.
• Jennie Jarrett: New role as Director of Science and Drug Policy, American Medical Association.
• Sylvia Ou: New Clinical Pharmacy Specialist – Ambulatory Care, Rush University Medical Center, Chicago, IL.

 

Awards

• Nada M. Farhat: 2022 Michigan Society of Health-System Pharmacists Pharmacist of the Year.
• Rhianna Fink: Preceptor of the Year, University of Colorado Skaggs School of Pharmacy PGY2 Ambulatory Care Residency Program.
• Deanna L. McDanel: Excellence in Innovation Award: Iowa Pharmacy Association; Sponsored by Upsher-Smith Laboratories, LLC, and the National Alliance of State Pharmacy Associations (NASPA), September 2022.
• Marissa Salvo: Scheduled to receive the APhA-APPM 2023 Distinguished Award in Service at the 2023 APhA Annual Meeting in March.

 

Grants

• Merna Tawadrous: ASHP Foundation Pharmacy Resident Research Grant, Ohio Northern University Raabe College of Pharmacy. Primary Investigator.

 

Publications

• Albanese NP. Systemic lupus erythematosus. In: Schwinghammer TL, et al., eds. Pharmacotherapy Casebook: A Patient-Focused Approach, 12th ed. McGraw-Hill, 2023.
• O’Brocta R, Albanese NP. Student self-evaluation of professionalism during advanced pharmacy practice experiences. Pharm Educ 2023;23:1-6.
• Cope K, DeMicco J, Salib J, et al. Three-year retention rates with office-based treatment of buprenorphine for opioid use disorder in a private family medicine practice. J Addict Med 2022;16:716-21.
• Cope R, Sulkow H. Theory-based educational and behavioral interventions to improve oral anticoagulant adherence. In: Duncan LT, ed. Advances in Health and Disease, vol. 63. Nova Science, 2023:207-36.
• Wong E, Cope R, Dima L, et al. Tirzepatide (Mounjaro): a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 agonist for the management of type 2 diabetes mellitus. Am J Ther 2023;30:e26-e35.
• Elmes AT, Hellenbart EL. Vericiguat (Verquvo) for the treatment of heart failure. Am Fam Physician 2022;106:582-3.
• Elmes AT, Holger D, Cieslak K, Desai D, Kunz Coyne A, Patel V, Rodgers JE, Jarrett JB. Post-graduate pharmacy fellowships: the current state of affairs. J Am Coll Clin Pharm 2023;6:145-53.
• Elmes AT, Loza J, Wells C, Jarrett JB. Newly diagnosed patients with type 2 diabetes: approach to evaluation and treatment. J Fam Pract 2022. [In press]
• Conley MP, Elmes AT, Roberts JR, et al. Developing an interprofessional team to support patients prescribed long-term high-dose opioid therapy. J Interprof Care 2023;37:320-4.
• Posen A, Keller E, Elmes AT, Messmer S, Gastala N, Neeb C, Jarrett JB. Access to medication-assisted recovery for opioid use disorder: current landscape and limitations. J Fam Pract Dec 2022. [In press]
• Goldman JD, Angueira-Serrano E, Gonzalez J, et al. Survey reveals patient and health care provider experiences and challenges with the use of high doses of basal insulin. Clin Diabetes 2022 Dec 6. [Epub ahead of print]
• Goldman JD, Dvorkin Camiel L. A new medical probiotic formulation for the management of type 2 diabetes. Clin Diabetes 2022;40:500-2.
• Goldman JD, Sangave N. Misdiagnosis of type 1 diabetes identified at a primary care pharmacist visit. Clin Diabetes 2022 Nov 10. [Epub ahead of print]
• Brunton S, Fishbane S, Goldman JD, Wright E. Anemia in CKD in primary care: executive summary. Clin Diabetes 2023;41:81-4.
• Choi H, Goldman J. Effects of antidiabetic medications on the risk of bone fracture in patients with type 2 diabetes mellitus. ADCES Pract 2022;10:10-4.
• Edelman S, Goldman JD, Malone D, et al. Real-world persistence, adherence, healthcare resource utilization, and hypoglycemia in people with type 2 diabetes who continued the second-generation basal insulin analog insulin glargine 300 U/mL or switched to a first-generation basal insulin analog (insulin glargine 100 U/mL or detemir). Clin Diabetes. [In press]
• Martinez A, Goldman JD. Efficacy and durability of combination treatment with glucagon-like peptide-1 receptor agonists and basal insulin. ADCES Pract 2022;10:42-5.
• Prisco JL, Goldman JD, Eguale T, et al. Important factors in remote experiential education. Pharmacy 2022;10:122.
• Hess R, Schumacher C, Whitley HP, Reece S, Knezevich EL, Dela Pena LE, Gross B, Knezevich JT, Ginzburg R, Albanese NP, Isaacs D. Diabetes technology: a primer highlighting the role of the pharmacist. J Am Coll Clin Pharm 2022;5:1307-23.
• Hwang AY, Cardel MI, Smith SM. Racial and ethnic differences in blood pressure before and after the 2016 United States general election. Am J Hum Biol 2022;34:e23785.
• Bradley CL, McMillin SM, Hwang AY, Sherrill CH. Tirzepatide, the newest medication for type 2 diabetes: a review of the literature and implications for clinical practice. Ann Pharmacother 2022 Nov 11. [Epub ahead of print]
• Lim L, Lipari M, Kale-Pradhan P. Intranasal olopatadine: mometasone in the treatment of seasonal allergic rhinitis. Ann Pharmacother 2022 Sep 19. [Epub ahead of print]
• Massmann A, Heukelom JV, Larson C, et al. Leveraging clinical decision support to reduce the risk of discordant pharmacogenomics results. Pharmacogenomics 2022;23:987-93.
• Petry NJ, Baye JF, Frear S, Jacobsen K, Massmann A, et al. Progression of precision statin prescribing for reduction of statin-associated muscle symptoms. Pharmacogenomics 2022;23:585-96.
• Petry NJ, Van Heukelom J, Baye JF, Massmann A. The effect of medication reconciliation on generating an accurate medication list in a pharmacogenomics practice. Ann Transl Med 2022;10:1259.
• Schumacher C. Severe hypotension with concomitant sodium-glucose co-transporter-2 inhibitor and angiotensin receptor-neprilysin inhibitor therapy in a patient with heart failure reduced ejection fraction: a case report. J Pharm Pract 2022 Nov 28. [Epub ahead of print]
• Bookstaver B, Bodan S, Chamberlin K, Hake K, Hong L, Kabbani R, McCormick A, Morris J, Schumacher C, et al. Postgraduate year one pharmacy residency equivalency – 2023. J Am Coll Clin Pharm 2023;6:291-6.
• Sherrill CH, Lee S. Prevalence, characteristics, and health-related quality of life of continuous glucose monitoring use according to the Behavioral Risk Factor Surveillance System 2014-2020. J Manag Care Pharm. [In press]
• Melendez DR, Bradley CL, Lee S, Sherrill CH. Transition from in-person to telehealth standardized patient encounters: a retrospective analysis of 18 cases. Curr Pharm Teach Learn 2022;14:1518-24.
• Soric MM. Overview of the hematologic system. In: Stuhan MA, ed. Understanding Pharmacology for Pharmacy Technicians, 2nd ed. American Society of Health-System Pharmacists, 2023:537-46.
• Soric MM. Overview of the cardiovascular and renal systems. In: Stuhan MA, ed. Understanding Pharmacology for Pharmacy Technicians, 2nd ed. American Society of Health-System Pharmacists, 2023:281-96.
• Soric MM. Hypertension. In: Stuhan MA, ed. Understanding Pharmacology for Pharmacy Technicians, 2nd ed. American Society of Health-System Pharmacists, 2023:297-316.
• Soric MM. Heart disease. In: Stuhan MA, ed. Understanding Pharmacology for Pharmacy Technicians, 2nd ed. American Society of Health-System Pharmacists, 2023:317-52.
• Soric MM. Hyperlipidemia. In: Stuhan MA, ed. Understanding Pharmacology for Pharmacy Technicians, 2nd ed. American Society of Health-System Pharmacists, 2023:353-65.
• Soric MM. Study designs: design and application. In: Bernhardt MB, Blackmer A, Cho HJ, et al., eds. Updates in Therapeutics^®: Pediatric Pharmacy Preparatory Review and Recertification Course, 2022 ed. American College of Clinical Pharmacy, 2022:827-56.
• Van Dril E, Schumacher C. Chronic kidney disease in people with diabetes. In: Sanoski CA, Witt DM, eds. Pharmacotherapy Self-Assessment Program. 2023 Book 1. Endocrinology and Nephrology. American College of Clinical Pharmacy, 2023:7-35.
• Vernon V, Patel J, Cieri-Hutcherson NE, Arellano R, Elmore H, Griffin B, Mitzel K, Moyeno WM, O’Connell MB, et al. The impact of COVID-19 on select considerations in patients of reproductive age: brief talking points for pharmacists. J Am Pharm Assoc (2003) 2023 Jan 11. [Epub ahead of print]
• Miller J, Opara M, Wheeler SE. Anticoagulation and blood disorders. In: Hoffmann-Eubanks B, ed. APhA NAPLEX Quick Review Guide, 2nd ed. American Pharmacists Association, 2023.
• Opara M, Wheeler SE. Endocrinology. In: Hoffmann-Eubanks B, ed. APhA NAPLEX Quick Review Guide, 2nd ed. American Pharmacists Association, 2023.
• White S, Morrow R, Pan I, de Zoeten EF. Riding the wave of adalimumab biosimilars: considerations for pediatric gastroenterologists. J Pediatr Gastroenterol Nutr. [In press]

 

Presentations

• Nicole Albanese: Updates in diabetes. Presented at: 2022 ACCP-Taiwan Virtual Pharmacotherapy Symposium; September 25, 2022; virtual.
• Michelle Balli:

DeLoach A, Balli ML, Terry T. Impact of clinical pharmacy interventions to improve guideline-directed therapy in patients with a hemoglobin A1C > 9%. Poster presented at: 2022 ASHP Midyear Clinical Meeting; December 2022; Las Vegas, NV.

Riccio KC, Balli ML, Fink R, et al. 2022 update on innovative practices amongst members of the ACCP Ambulatory Care Practice and Research Network. Poster presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

Thomas J, Balli ML. Comparison of standardized patient versus pharmacist evaluation of student performance on a blood pressure technique assessment. Poster presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

Balli ML, Thomas J. Impact of time since completion of immunization certificate training on performance in a community-based immunization objective structured clinical examination (OSCE). Poster presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

• Rebecca Cope: Badran H, Kim KY, Cope R, Sarsour M, Quinn R, Sasson E. Appropriateness of apixaban dosing before and after implementation of an order set in an inpatient setting at a community teaching hospital. Poster presented at: ASHP Midyear Clinical Meeting; December 2022; Las Vegas, NV.
• Andrew Hwang: What is the best blood pressure goal? Depends on who you ask. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Sylvia Ou, Nancy L. Shapiro: Sylvia Ou; Erin Pozzolano; Avisek Datta; Dulal Bhaumik; Nancy L. Shapiro. Aspirin deprescribing in patients on oral anticoagulation for atrial fibrillation or venous thromboembolism: a national survey of clinician practices. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Jaini Patel: Preeclampsia and eclampsia treatment and prevention. Presented at: Midwestern University’s Chicago College of Osteopathic Medicine Grand Rounds; January 2023; Chicago, IL.

• Christie Schumacher:

Association of Diabetes Care and Education Specialists (ADCES) Live Webinar: The prevention and management of heart and kidney disease in people with diabetes; October 21, 2022; virtual.

Ours vs. theirs: professional vs. personal CGM and how to integrate CGM into clinical practice. Keynote presentation for physicians and diabetes care and education specialists. Harold Hamm Diabetes Care Summit; August 2022; Oklahoma City, OK.

• Christie Schumacher, Elizabeth Van Dril: Building the case for SGLT2 inhibitors in diabetes-related CKD. Presented for continuing education credit to pharmacists, pharmacy residents, fellows, and students. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Christina Sherrill: Effect of pharmacist-driven continuous glucose monitoring in adults with uncontrolled diabetes. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Mate Soric: Study designs: design and application. Presented at: American College of Clinical Pharmacy Updates in Therapeutics^®: Pediatric Pharmacy Preparatory Review and Recertification Course Webinar; December 2022; virtual.

 

New ACCP Fellows

• Shubha Bhat
• Gregory Castelli
• Michelle A. Fravel
• Adriane N. Irwin
• Jenna K. Lovely
• Emily K. McCoy
• Golden L. Peters
• Sara W. Reece
• Sheila L. Stadler
• Pamela L. Stamm
• Kathleen Vest

 

Other Notable Achievements

• Nicole Albanese: Faculty Panel Chair for next Ambulatory Care Self-Assessment Program (ACSAP) Book: Endocrinology Care.
• Mary Mekheil:

BCCP

Selected for Pharmacotherapy Specialty Council for BPS.

• Sylvia Ou: BCACP

 

 

 

Promotions

• Andrew Smith: Clinical Professor, UMKC School of Pharmacy.

 

Awards

• DiDomenico RJ, Shapiro NL, Badowski ME. University of Illinois Chicago College of Pharmacy, Frederick P. Siegel Innovative Teaching Award (Clinical Research Design Elective Course).
• Madeline Fuller: Service Award, Cardiology PRN, American College of Clinical Pharmacy.
• McQuade BM, Reed BN, DiDomenico RJ, Baker WL, et al. 2022 JACCP Editor’s Choice Award. Feeling the burn? A systematic review of burnout in pharmacists. J Am Coll Clin Pharm 2020;3:663-75.
• Erica Sheridan: Toledo Area Society of Health-System Pharmacists (TASHP) Pharmacist of the Year Award.
• Tiffany Vatterrodt; Kelly Cochran; Taylor Hibner; Sydney Rapp; Lindsey Greiner (as part of the Community Health Network Anticoagulation Clinics) – Indianapolis Coalition for Patient Safety, Patient Safety Hero Award received November 2022.

 

Grants

• Coons JC: Implementing Risk-Based Preemptive Pharmacogenomic (PGx) Testing in Employee Health. Precision Medicine Implementation Program (PreMIP). Institute for Precision Medicine, University of Pittsburgh and UPMC. Co-Investigator ($1 million).
• DiDomenico RJ, Siemer M: Service, Building Health Communities in Suburban Cook County: Suburban Cook County Community Health Workers Initiative (Cook County Department of Public Health; H22-25-147). Co-PIs.
• Patil T, Kaur A, Paarlberg J: Improving Statin Adherence in Underserved Patient Population. Operational grant by Office of Health Equity, VHA ($19,080).

 

Publications

• Baker WL, Jaiswal A. Evaluation of a flexible weight and height interaction versus body mass index for mortality prediction after adult heart transplant. Exp Clin Transplant 2022;20:849-53.
• Baker WL, Moore TW, Baron E, Jennings DL, et al. Development and validation of a model to predict malignancy within the first year after adult heart transplantation. Prog Transplant 2022 Dec 20. [Epub ahead of print]
• Jaiswal A, Baran DA, Sinphurmsukskul S, Baker WL. Cardiac donors with renal impairment: usage and outcomes after heart transplant. Clin Transplant 2022;36:e14767.
• Buckley LF, Baker WL, Van Tassell BW, Cohen JB, Alkezi O, Bress AP, Dixon DL. Systolic blood pressure time in target range and major adverse kidney and cardiovascular events. Hypertension 2023;80:305-13.
• Chow SL, Bozhurt B, Baker WL, Bleske BE, et al. Complementary and alternative medicines in the management of heart failure: a scientific statement from the American Heart Association. Circulation 2023;147:e4-e30.
• Coons JC, Kliner J, Mathier MA, et al. Impact of a medication optimization clinic on heart failure hospitalizations. Am J Cardiol 2022;188:102-9.
• Coons JC, Stevenson JM, Patel A, et al. Antiplatelet therapy and bleeding outcomes with CYP2C19 genotyping. J Cardiovasc Pharmacol Ther 2022;27:10742484221143246.
• McFarland MS, Stover KR, Bhat S, Coon S, Cooper M, DiDomenico RJ, et al. Charting a new path forward for pharmacy residency expansion. J Am Coll Clin Pharm 2023 Jan 4. [Epub ahead of print]
• Sheehan AH, DiDomenico RJ. Postgraduate pharmacy training: much progress and much more to do. J Am Coll Clin Pharm 2023;6:88-9.
• Gibson CM, Gordon S, White A, et al. An assessment of patient experiences as teachers of cultural sensitivity in an interprofessional setting. Curr Pharm Teach Learn 2022;14:1032-9.
• Gibson CM, Larson S, Behnen EM, et al. Feeding the soul: the impact of community circles on the AACP Women Faculty SIG. Am J Pharm Educ 2022;86:Article 8927.
• Drame I, Gibson CM, Nonyel NP, et al. Toward a programmatic approach for health disparities and cultural competency training: curriculum and co-curriculum. Am J Pharm Educ 2022;86:Article 8631.
• Akioyamen L, Chu A, Genest J, Lee DS, Abel-Qadir H, Jackevicius CA, et al. Prevalence and treatment of familial hypercholesterolemia and severe hypercholesterolemia in Ontario, Canada. Can J Cardiol Open 2022;4:739-47.
• Patel S, Thompson W, Sivaswamy A, Khan A, Ferreira-Legere L, Lee DS, Abdel-Qadir H, Jackevicius CA, et al. Development and validation of a model to categorize cardiovascular cause of death using health administrative data. Am Heart J Plus 2022;22:100207.
• Shurrab M, Jackevicius CA, Austin PC, et al. Association between concurrent use of amiodarone and DOACs and bleeding risk in atrial fibrillation patients. Am J Cardiol 2023;186:58-65.
• Shurrab M, Jackevicius CA, Austin PC, et al. Association between concurrent use of diltiazem and DOACs and risk of bleeding in atrial fibrillation patients. J Interv Card Electrophysiol 2022 Sep 23. [Epub ahead of print]
• Verma A, Fonarow GC, Hsu JJ, Jackevicius CA, et al. The design of the Dashboard Activated Services and Telehealth for Heart Failure (DASH-HF) study: a pragmatic quality improvement randomized implementation trial for patients with heart failure with reduced ejection fraction. Contemp Clin Trials 2022;120:106895.
• Warner AL, Lu L, Ghaznavi Z, Jackevicius CA. Inpatient quality-of-care measures for heart failure: treatment gaps and opportunities in the contemporary era. Circ Cardiovasc Qual Outcomes 2022;15:e008936.
• Jennings DL, Baker WL. Impact of the United Network for Organ Sharing policy change on induction immunosuppression practice patterns and outcomes in adult heart transplant recipients. Pharmacotherapy 2023;43:115-21.
• Ball NS, Knable BM, Relich TA, Smathers AN, Gionfriddo MR, Nemecek BD, Montepara CA, et al. Xylazine poisoning: a systematic review. Clin Toxicol (Phila) 2022;60:892-901.
• Skersick PT, Proco D, Sharma-Huynh P, Montepara CA, Rodgers JE. Evaluating the evidence for sacubitril/valsartan across the continuum of heart failure. Pharmacotherapy 2022;42:837-48.
• Pizula J, Devera J, Ng TMH, et al. Outcome of pregnancy in women with D-transposition of the great arteries: a systematic review. J Am Heart Assoc 2022;11:e026862.
• Wong PJ, Mosley S, Ng TMH, et al. Changes in anticoagulant and antiplatelet drug supply at U.S. hospitals before and during the COVID-19 pandemic (2018-2021). Am J Health Syst Pharm 2022 Dec 26. [Epub ahead of print]
• Patil T, Ali S, Kaur A, et al. Impact of pharmacist-led heart failure clinic on optimization of guideline-directed medical therapy (PHARM-HF). J Cardiovasc Transl Res 2022;15:1424-35.
• Patil T, Halsey E, Kaur A, et al. CHAnges in Diuretic Medication Prescribing and Surrogate Laboratory Parameters After Initiating EmpagliflOziN in Veterans (CHAMPION Cohort Study). Clin Drug Investig 2023;43:61-74.
• Shringi S, Joshi S, Suffredini JM, Schenk A, et al. Long-term ambulatory intravenous milrinone therapy in advanced heart failure. Heart Lung Circ 2022;31:1630-9.
• Schumacher C. Severe hypotension with concomitant sodium-glucose co-transporter-2 inhibitor and angiotensin receptor-neprilysin inhibitor therapy in a patient with heart failure reduced ejection fraction: a case report. J Pharm Pract 2022 Nov 28. [Epub ahead of print]
• Carpenter JS, Cortés YI, Tisdale JE, et al. Palpitations across the menopause transition in SWAN: trajectories, characteristics and associations with subclinical cardiovascular disease. Menopause 2023;30:18-27.
• Gallo T, Heise CW, Woosley RL, Tisdale JE, et al. Clinician satisfaction with advanced clinical decision support to reduce the risk of torsades de pointes. J Patient Saf 2022;18:e1010-e1013.
• Rowe EJ, Shugg T, Ly RC, Philips S, Rosenman MB, Callaghan JT, Radovich M, Overholser BR, Schneider BP, Tisdale JE, et al. Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer. Front Cardiovasc Med 2022;9:894623.
• Ueoka A, Sung YL, Liu X, Rosenberg C, Chen Z, Everett TH, Rubart M, Tisdale JE, et al. Testosterone does not shorten action potential duration in Langendorff perfused rabbit ventricles. Heart Rhythm 2022;19:1864-71.
• Stone KH, Reynolds K, Davis S, Van Tassell B, Gibson CM. Comparison of new-onset post-operative atrial fibrillation between patients receiving carvedilol vs. metoprolol after coronary artery bypass graft surgery. Gen Thorac Cardiovasc Surg 2022 Sep 30. [Epub ahead of print]
• Van Tuyl JS. Optimal management of chronic heart failure during hospitalization. In: Boucher BA, Haas CE, eds. Cardiology Self-Assessment Program, 2022 Book 1. Heart Failure. American College of Clinical Pharmacy, 2022:45-60.
• Houry EA, Gengler BE, Alberts JL, Van Tuyl JS. Evaluation of thrombocytopenia in patients receiving percutaneous mechanical circulatory support with an Impella device. Crit Care Explor 2022;4:e0772.

 

New ACCP Fellows

• Bassam Atallah

 

Other

• Elena Buff: BCCP
• Kate Cabral: Elected to fellowship status to ACC (FACC).
• Shannon Finks: Elected to ACCP Board of Regents, October 2022.
• Madeline Fuller: BCCP
• Natalie Kong: Promoted to PGY1 Residency Program Director, Lankenau Medical Center.
• Brian Lopez: BCCP
• Ashley Schenk:

Designated as Associate of the American College of Cardiology.

PGY2 Cardiology Residency Assistant Program Director, UK HealthCare.

 

 

 

Promotions/New Positions

• Carolyn O’Donnell: Accepted a new position as a Pharmacy Clinical Specialist in Mental Health, Hines VA, Chicago, IL.

 

Publications

• Grinalds MS, Yoder C, Krauss Z, Chen AM, Rhoney DH. Scoping review of rational polytherapy in patients with drug-resistant epilepsy. Pharmacotherapy 2023;43:53-84.
• Light J, Ruh C, Ott M, et al. The effect of pharmacy-led medication reconciliation on odds of psychiatric relapse at a community hospital. J Pharm Pract 2022 Oct 31. [Epub ahead of print]
• Kosobuski L, O’Donnell C, Koh-Knox Sharp CP, et al. The role of the pharmacist in combating the opioid crisis: an update. Subst Abuse Rehabil 2022;13:127-38.
• Ju V, Walkerly A, VandenBerg A, et al. New onset of seizures and psychosis in a patient who is coprescribed atomoxetine and bupropion: a case report. J Clin Psychopharmacol 2022;42:600-2.

 

Other Notable Achievements

• Stephanie Nichols: Elected Chair, Maine Prescription Monitoring Program Advisory Council.

 

 

 

Promotions

• Tyler Vest: Associate Chief Pharmacy Officer, Inpatient Pharmacy Services and System Automation, Duke University Health System.

 

Awards

• Tyler Vest: 2023 ASHP Best Practices Award.

 

Publications

• Clark J, Fera T, Fortier C, Gullickson K, Hays A, Murdaugh L, Ogden R, O’Neal B, Rush J, Vest TA. ASHP guidelines on preventing diversion of controlled substances. Am J Health Syst Pharm 2022;79:2279-306.
• Gazda NP, Vest TA, Peek GK, et al. A new perspective: practice-enhancing publications about the ambulatory care medication use process in 2020. Am J Health Syst Pharm 2022;79:1697-727.

 

 

 

Awards

• Sophie Herbert: Participant, American Pharmacists Association (APhA) COVID-19 Vaccine Learning Collaborative.

 

Publications

• Adeoye-Olatunde OA. Advancing pharmacy technician roles in addressing social determinants of health. J Am Pharm Assoc 2023;63:3-4.
• Bacci JL, Ferreri SP, Coley KC, Daly CJ, Hake KL, Herbert SM, Hughes TD, McDonough RP, Roller JS, McGivney MS, et al. Qualitative analysis of a community pharmacy practice transformation initiative. J Am Coll Clin Pharm 2022;5:1236-52.
• Turco E, Carroll JC, McGivney MS, McGrath SH, Herbert SMC, Firm A, Coley KC. Coaching strategies for the Flip the Pharmacy practice transformation initiative in Pennsylvania independent community pharmacies. J Am Pharm Assoc (2003) 2023;63:164-8.
• Waghmare PH, Huang CY, Jaynes HA, Green WM, Snyder ME, Adeoye-Olatunde OA, et al. Disparities in Medicare beneficiaries’ receiving medication synchronization. J Am Pharm Assoc 2022 Oct 22. [Epub ahead of print]

 

Presentations

• Omolola A. Adeoye-Olatunde:

Journey toward social impact through community-based health services. Invited speaker at: Lead Forward Luminary Event; February 2023; West Lafayette, IN.

The road less traveled: establishing a health equity research institute within a college of pharmacy program. Invited speaker at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

Healthcare Panel – Older adult safety and wellness during the pandemic. Invited panelist at: CICOA Aging Advantages Faith Summit; October 2022; Indianapolis, IN.

Health Equity Council – A community health worker workforce development update. Invited speaker at: Minority Health Partners Conference; September 2022; Indianapolis, IN.

Engaging community health workers (CHWs) in research to advance health equity. Invited speaker at: Regenstrief Center for Healthcare Engineering Summit; September 2022; West Lafayette, IN.

Development of a social determinants of health (SDOH)-centered adapted Pharmacists’ Patient Care Process (PPCP). Poster presented at: Regenstrief Center for Healthcare Engineering Summit; September 2022; West Lafayette, IN.

What predicts older adults’ self-reported medication deprescribing behaviors? The intertwined roles of social determinants of health and health beliefs. Poster presented at: Purdue University College of Pharmacy Research Day; November 2022; West Lafayette, IN.

Meeting people where they are: a novel naloxone distribution program offered at food pantries and homeless shelters. Presented at: Harm Reduction Conference; October 2022; San Juan, Puerto Rico.

• Ballou J:

Beyond dispensing: community pharmacy practice transformation through CPESN. Presented at: South Carolina Pharmacy Association Southeastern Women of Pharmacy Leadership Weekend; January 2023; Asheville, NC.

The winter blues: community pharmacy management of depression and anxiety. Presented at: McKesson ideaShare; February 2023; virtual.

• Hettinger KN, Adeoye-Olatunde OA, Snyder ME. Barriers, facilitators, and recommendations for implementing health information exchange in community pharmacies. Poster presented at: Academy Health Annual Conference on the Science of Dissemination and Implementation; December 2022; Washington, DC.
• Hettinger KN, Russ-Jara AL, Adeoye-Olatunde OA, Snyder ME. A developmental, formative evaluation to inform implementation of bidirectional health information exchange in community pharmacies. Poster presented at: Indiana Clinical and Translational Sciences Institute Annual Meeting; September 2022; Indianapolis, IN.

 

 

 

Promotions

• Michael Behal: Associate Adjunct Professor, College of Pharmacy, University of Kentucky.
• Megan Feeny: Clinical Pharmacy Coordinator, Critical Care Boston Medical Center.
• Nick Nelson: Assistant Professor, School of Pharmacy, Wingate University.

 

Awards

• Michael Behal:

PRN Resident/Fellow Travel Award, ACCP Critical Care PRN.

Star Research Award, Society of Critical Care Medicine.

• Kara Birrer:

2022 Distinguished Service Award, Florida Society of Health-System Pharmacists.

Random Act of Kindness Award, Orlando Health ORMC Random Act of Kindness Award.

• Christopher Buckley: 2022 Junior Investigator of the Year Award, ACCP Critical Care PRN.
• Jessica Cercone:

2023 Young Pharmacist Investigator Award, Patient Safety, CPP Section, Florida Society of Health-System Pharmacists.

Orlando Health ORMC Random Act of Kindness Award.

• Aaron Chase: 2022 Resident Investigator Award, ACCP Critical Care PRN.
• Deepali Dixit: 2022 Achievement Award, ACCP Critical Care PRN.
• Chris Droege: Cookie Award, Society of Critical Care Medicine Ohio Chapter.
• Mojdeh Heavner:

Editor’s Choice Award, Pharmacotherapy.

Preceptor of the Year Award, School of Pharmacy, University of Maryland.

• Tudy Hodgman: 2023 Distinguished Service Award, Society of Critical Care Medicine.
• Judith Jacobi: 2022 Outstanding Reviewer for JACCP, Pharmacotherapy Publications, Inc.
• Michael Kenes:

Phi Delta Chi Faculty Teaching Award, P3 Class of 2023, College of Pharmacy, University of Michigan.

2023 Congress Scholarship Award, Research Section, Society of Critical Care Medicine.

• Ty Kiser: 2023 Distinguished Service Award, CPP Section, Society of Critical Care Medicine.
• Neha Naik: Star Research Award, Society of Critical Care Medicine.
• Andrea Nei: 2022 Clinical Practitioner Award, ACCP Critical Care PRN.
• Scott Nei: 2022 Mentor of the Year Award, ACCP Critical Care PRN.
• Nick Nelson: 2022 Best Resident/Fellow Poster Award, ACCP.
• Paul Reynolds: 2022 Education Award, ACCP Critical Care PRN.
• Andrea Sikora (on behalf of the MRC-ICU Investigator Team): Publication of the Year Award, ACCP Critical Care PRN.
• Susan Smith: Presidential Citation Award, Society of Critical Care Medicine.
• Joe Swanson: Preceptor of the Year (Full-Time Faculty), College of Pharmacy, University of Tennessee.
• G. Christopher Wood: 2022 Research Award, ACCP Critical Care PRN.

 

Grants

• Chris Droege: Co-Investigator, Pharmacostability of Medications Exposed to Cold Environments. United States Air Force School of Aerospace Medicine, En Route Care Research Division Proposal; USAF Grant Number: FA8650-21-2-6285, 2022-2025 ($749,662).
• Megan Feeney: Principal Investigator, ACCP Futures Grant ($30,000).
• Susan Smith:

Co-Investigator. Machine Learning Validation of Medication Regimen Complexity for Critical Care Pharmacist Resource Prediction. U.S. Department of Health & Human Services R21 ($296,168).

Co-Investigator. Artificial Intelligence-Based Health IT Tools to Optimize Critical Care Pharmacist Resources Through Adverse Drug Event Prediction. U.S. Department of Health & Human Services R01 ($1,890,488).

 

Publications

• Behal ML, Cook AC. Multicenter resident research – let’s go. J Pharm Pract 2022 Oct 15. [Epub ahead of print]
• Kenneally AM, Behal ML, Mefford BM, Beckman EJ. Survey of critical care pharmacists on sedation and analgesia practices in adult and pediatric patients receiving continuous neuromuscular blocking agents. J Am Coll Clin Pharm 2022 Dec 22. [Epub ahead of print]
• Whitenack K, Behal ML, Thompson Bastin ML, Aycinena JC, Adams PM, Flannery AH. Progression of kidney injury with the combination of vancomycin and piperacillin-tazobactam or cefepime in sepsis-associated acute kidney injury. Front Nephrol 2022;2:995358.
• Wiegand AM, Behal ML, Robbins BT, Pandya KA, et al. Niche roles for dexmedetomidine in the intensive care unit. Ann Pharmacother 2023 Jan 31. [Epub ahead of print]
• Bolesta S. Specialized topics in cardiovascular disease. In: Baker WL, Berei T, Bolesta S, et al., eds. Updates in Therapeutics^®: Cardiology Pharmacy Preparatory Review Course, 2022 ed. American College of Clinical Pharmacy, 2022:641-80.
• Bolesta S, Burry L, Perreault M, Gélinas C, Smith K, Carini F, Eadie R, Saltarelli K, Mitchell J, Harpel J, Stewart R, Riker R, Fraser G, Erstad B. International analgesia and sedation weaning and withdrawal practices in critically ill adults: the AduLt iatrogEnic withdRawal sTudy in the ICU (ALERT-ICU). ESICM LIVES 2022: part 1 [abstract]. Intensive Care Med Exp 2022;10:239.
• Ivey KA, Bolesta S. Impact of pharmacist monitoring of serum triglycerides for critically ill patients receiving propofol. J Pharm Pract 2022 Oct 14. [Epub ahead of print]
• Bradshaw PG, Keegan SP, Droege ME, Harger Dykes NJ, Ernst NE, Foertsch MJ, Makley AT, Mueller EW, Philpott CD, Srinivasan V, Winter JB, Goodman MD, Droege CA. Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures. Pharmacotherapy 2022;42:780-91.
• Brown CS, Sarangarm P, Faine B, Rech MA, Flack T, Gilbert B, Howington GT, Laub J, Porter B, et al. A year reviewed: top emergency medicine pharmacotherapy articles of 2021. Am J Emerg Med 2022 Jul 25. [Epub ahead of print]
• McFarland MS, Buck M, Finks SW, Jacobi J, et al. The Outcomes of Implementing and Integrating Comprehensive Medication Management in Team-Based Care: A Review of the Evidence on Quality, Access and Costs, December 2022. Get the Medications Right Institute, December 2022.
• Cercone J, Kram S, Trammel M, et al. Effect of initial anticoagulation targets on thrombotic and bleeding complications for patients with acute respiratory distress syndrome receiving extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth 2022;36:3561-9.
• Frankart LM, Patterson JA, Crawford AN, et al. Retention of students’ knowledge of immunizations following a one-day or a five-week course. Curr Pharm Teach Learn 2022;14:1104-8.
• Cucci M, Palm N, Vazquez D, Mullen C, Heavner MS. Survey of critical care practices for alcohol withdrawal syndrome in the intensive care unit. J Am Coll Clin Pharm 2022;5:950-8.
• Dickerson RN, Andromalos L, Brown JC, et al. Obesity and critical care nutrition: current practice gaps and directions for future research. Crit Care 2022;26:283.
• Dickerson RN, Bingham AL, Canada TW, et al. Significant published articles in 2021 for pharmacy nutrition support practice. Hosp Pharm 2022;57:673-80.
• Dickerson RN, Turner SC, Holmes WL, Van Matre ET, Swanson JM, et al. Reduction in hypercalcemia following readjustment of target serum 25-hydroxy vitamin D concentration during cholecalciferol therapy in vitamin D-deficient, critically ill patients. Nutrients 2022;14:1650.
• Nathwani JN, Baucom MR, Salvator A, Makley AT, Tsuei BJ, Droege CA, et al. Evaluating the utility of high sensitivity troponin in blunt cardiac injury. J Surg Res 2023;281:104-11.
• Singer KE, Kodali RA, Wallen TE, Salvator A, Pritts TA, Droege CA, et al. The association of norepinephrine utilization with mortality risk in trauma patients. J Surg Res 2022;280:234-40.
• Wallen TE, Elson NC, Singer KE, Hayes HV, Salvator A, Droege CA, et al. Evaluation of the impact of tracheostomy on analgesic and sedative requirements in mechanically ventilated patients. J Trauma Acute Care Surg 2022;93:545-51.
• Hamilton LA, Kiles TM, Hohmeier KC. Black student perspectives to inform actionable steps toward diversity, equity, and inclusion in pharmacy residency programs. J Am Coll Clin Pharm 2022. [In press]
• Kiles TM, Hamilton LA, Hohmeier KC. “Following your dreams, not killing yourself to do so” – Black student perceptions of residency. Am J Pharm Educ 2023. [In press]
• Heavner MS, Gorman EF, Linn DD, Yeung SYA, et al. Systematic review and meta-analysis of the correlation between bispectral index (BIS) and clinical sedation scales: towards defining the role of BIS in critically ill patients. Pharmacotherapy 2022;42:667-76.
• Heavner MS, Heavner JJ. Pain, agitation, and delirium in critical care. In: Schwinghammer TL, et al., eds. Pharmacotherapy Casebook: A Patient-Focused Approach, 12th ed. McGraw-Hill, 2023.
• Heavner MS, Louzon PR. Effects of common ICU medications on sleep in the ICU. In: Weinhouse GL, Devlin JW, eds. Sleep in Critical Illness: Physiology, Associated Outcomes, and its Potential Role in Recovery. Springer Nature, 2022.
• Chudow MB, Condeni MS, Dhar S, Heavner MS, Nei AM, et al. Current practice review in the management of acute respiratory distress syndrome. J Pharm Pract 2022 Jun 21. [Epub ahead of print]
• Knauert MP, Ayas NT, Bosma KJ, Drouot X, Heavner MS, Owens RL, Watson PL, Wilcox ME, Anderson BJ, Cordoza ML, Devlin JW, et al. Causes, consequences, and treatments of sleep and circadian disruption in the intensive care unit: an official American Thoracic Society research statement. Am J Respir Crit Care Med. [In press]
• Miklich MA, Heavner MS. 2023. Drug-induced pulmonary diseases. In: Haines ST, Nolin TD, Ellingrod VL, eds. Pharmacotherapy: A Pathophysiologic Approach, 12th ed. McGraw-Hill Education, 2023.
• Chau T, Joseph M, Solomon DM, Lee B, Igneri LA. Heparin resistance in SARS-CoV-2 infected patients with venous thromboembolism. Hosp Pharm 2022;57:737-43.
• Lipski M, Pasciolla S, Wojcik K, Jankowitz B, Igneri LA. Comparison of 4-factor prothrombin complex concentrate and andexanet alfa for reversal of apixaban and rivaroxaban in the setting of intracranial hemorrhage. J Thromb Thrombolysis 2022 Dec 25. [Epub ahead of print]
• Pham C, Goldenberg-Sandau A, Sensenig R, Chau T, Igneri LA, et al. Phenobarbital for the management of alcohol withdrawal syndrome in critically ill, surgical-trauma patients. J Surg Res 2023;238:965-72.
• Rafeq R, Igneri LA. Infectious pulmonary diseases. Emerg Med Clin North Am 2022;40:503-18.
• Nesbit SA, Haas CE, Carter BL, Kehoe WA, Jacobi J, et al. Development of clinical pharmacy quality measures: a call to action. J Am Coll Clin Pharm 2022;5:366-9.
• Garcia MA, Johnson SW, Sisson EK, Sheldrick CR, Kumar VK, Boman K, Bolesta S, et al.; from the Society of Critical Care Medicine’s Discovery Viral Infection and Respiratory Illness Universal Study Investigators. Variation in use of high-flow nasal cannula and noninvasive ventilation among patients with COVID-19. Respir Care 2022;67:929-38.
• Patel JS, Kooda K, Igneri LA. A narrative review of the impact of extracorporeal membrane oxygenation on the pharmacokinetics and pharmacodynamics of critical care therapies. Ann Pharmacother 2022 Oct 15. [Epub ahead of print]
• Barlow B, Landolf K, LaPlante R, Cercone J, Kim JY, Ghorashi S, Howell A, Armahizer M, Heavner MS. Electrolyte considerations in targeted temperature management. Am J Health Syst Pharm 2023;80:102-10.
• Reid NK, Joyner KR, Lewis-Wolfson TD. Baricitinib versus tocilizumab for the treatment of moderate to severe COVID-19. Ann Pharmacother 2022 Oct 29. [Epub ahead of print]
• Knight RV, McDowell M, Lyons N, Faine BA, Rech MA. Pharmacist authors of emergency medicine organization work products pertaining to pharmacotherapy. Am J Health Syst Pharm 2022 Sep 7. [Epub ahead of print]
• Knight RV, McDowell M, Lyons N, Faine BA, Rech MA. Response to Awad et al. Am J Health Syst Pharm 2022 Nov 14. [Epub ahead of print]
• Krikorian SA, Moukhachen O, Flannery AH. Acute kidney injury. In: Zeind CS, Carvalho MG, Cheng JW, et al., eds. Applied Therapeutics: The Clinical Use of Drugs, 12th ed. Wolters Kluwer, 2023.
• Patel J, Medas R, Donnelly J, Mullins B. Efficacy of liposomal bupivacaine for sternotomy pain after cardiac surgery: a retrospective analysis. Ann Pharmacother 2022;56:1113-8.
• Nelson NR, Mendoza C, Rhoney DH. Augmented renal clearance in the hematology and oncology populations: a scoping review for pharmacists. J Pharm Pract 2022 Aug 16. [Epub ahead of print]
• Nelson NR, Rhoney DH. Analysis of expert feedback to determine intellectual standards for student clinical reasoning. Am J Pharm Educ 2022;86:8975.
• Rech MA, Gomez TA. What generates critical care pharmacist positions in the “real world”? Am J Health Syst Pharm 2022;79:1513-4.
• Rech MA, Gottlieb M. Can’t stop, won’t stop: the return of tranexamic acid for epistaxis. Ann Emerg Med 2022;80:189-91.
• Bell CM, Rech MA, Akuamoah-Boateng KA, Kasotakis G, McMurray JD, Moses BA, Mueller SW, Patel GP, Roberts RJ, Sakhuja A, Salvator A, Setliff EL, Droege CA. Ketamine in critically ill patients: use, perceptions, and potential barriers. J Pharm Pract 2022 Oct 25. [Epub ahead of print]
• Bell CM, Rech MA, Boateng KA, Kasotakis G, McMurray JD, Moses BA, Mueller SW, Patel GP, Robert RJ, Sakhuja A, Setliff E, Droege CA. Ketamine in critically ill patients: use, perceptions, and potential barriers. J Pharm Pract 2022 Oct 25. [Epub ahead of print]
• Faine BA, Rech MA, Vakkalanka P, Gross A, Brown C, Harding SJ, Slocum G, Zimmerman D, Zepeski A, Rewitzer S, Howington GT, Campbell M, Dawson J, Treu CN, Nelson L, Jones M, Flack T, Porter B, Sarangarm P, Mattson AE, Bailey A, Kelly G, et al. High prevalence of fluoroquinolone-resistant UTI among US emergency department patients diagnosed with urinary tract infection, 2018-2020. Acad Emerg Med 2022 Jun 2. [Epub ahead of print]
• Schmidt K, Bolesta S. Supportive management of sepsis. In: Dodds Ashley E, Gross A, eds. Infectious Diseases Self-Assessment Program, 2022 Book 2. Infections in Critically Ill Patients. American College of Clinical Pharmacy, 2022:35-58.
• Sikora A, Ayyala D, Rech MA, Blackwell SB, Campbell J, Caylor MM, Condeni MS, DePriest A, Dzierba AL, Flannery AH, Hamilton LA, Heavner MS, Horng M, Lam J, Liang E, Montero J, Murphy D, Plewa-Rusiecki AM, Sacco AJ, Sacha GL, Shah P, Smith MP, Smith Z, Radosevich JJ, et al.; MRC-ICU Investigator Team. Impact of pharmacists to improve patient care in the critically ill: a large multicenter analysis using meaningful metrics with the medication regimen complexity-ICU (MRC-ICU). Crit Care Med 2022;50:1318-28.
• Janzen KM, Kinney S, Shields KM, Tetenbaum-Novatt J, Mandal M, Owens RE, Seeger C, Smith SE, Tran E, Wagner JL, Zitko K, Kinney J, et al. Mentorship landscape and common practices in an academic pharmacy association. Am J Pharm Educ. [In press]
• Johnson BR, Logan LD, Darley A, Stone RH, Smith SE, et al. A scoping review for debate-style journal clubs in health professional education. Am J Pharm Educ. [In press]
• Lawing L, Yook J, Ray M, Smith SE. An evaluation of time to therapeutic range of intravenous unfractionated heparin after transitioning from direct oral factor Xa inhibitors. Hosp Pharm 2023;58:70-8.
• Cascone AE, Sullivan J, Ackerbauer K, Patel S, Kebadjian Lindale K, Tatro H, Feeney ME. Pharmacist-initiated de-prescribing efforts reduce inappropriate continuation of acid-suppression therapy initiated in the intensive care unit. Am J Med 2023;136:186-92.
• Walton MN, Hamilton LA, Salyer S, Wiseman BF, Forster AM, Rowe AS. Major bleeding postadministration of tenecteplase versus alteplase in acute ischemic stroke. Ann Pharmacother 2022 Aug 24. [Epub ahead of print]
• Weant KA, Acquisto NM, Doyno CR, Gregory H, Rech MA, Schlobohm CJ, Smith AP, et al. Development of an emergency medicine pharmacy intensity score tool. Am J Health Syst Pharm 2023;80:215-21.
• Webb AJ, Brown CS, Rech MA. Recent use of non-vitamin K antagonist oral anticoagulants and intracranial hemorrhage among patients with acute ischemic stroke treated with alteplase. JAMA 2022;327:2354-5.

 

New ACCP Fellows

• Scott Benken
• Chris Droege
• Megan Rech
• Adrian Wong

 

Other Notable Achievements

• Michael Behal:

BCCCP

Student, Resident, Fellow Liaison, ACCP Critical Care PRN.

• Grace Benanti: PGY2 Critical Care Pharmacy Residency Program Director, Loyola University Medical Center.
• Angela Bingham: FCCM – American College of Critical Care Medicine.
• Kara Birrer: Vice Chair, Medication Supply Management Committee, Orlando Health.
• Scott Bolesta: BCCCP
• Trisha Branan: FCCM – American College of Critical Care Medicine.
• Gretchen Brophy: MCCM – American College of Critical Care Medicine.
• Caitlin Brown: FCCM – American College of Critical Care Medicine.
• Jessica Cercone: BCCCP
• Alexis Crawford:

Education Committee Chair, Virginia Society of Health-System Pharmacists.

Selected for the COF Junior Faculty Connect Community Leadership Committee, American Association of Colleges of Pharmacy.

• Alexandra DeWitt: BCCCP
• Roland Dickerson: Appointed to Editorial Board, Journal of Parenteral and Enteral Nutrition.
• Deepali Dixit: Secretary-Treasurer, Critical Care PRN.
• Matthew Duprey: Social Media Committee Chair, Critical Care PRN.
• Julie Farrar: Membership Committee Chair, Critical Care PRN.
• Alex Flannery:

FASHP – American Society of Health-System Pharmacists.

Associate Editor, American Journal of Health-System Pharmacy.

• Leslie Hamilton:

Chair-Elect, Neurocritical Care Society Pharmacy Section.

Chair, ACCP FCCP Credentials: Fellowship Committee.

• Anthony Hawkins: Trainee Engagement Committee Chair, Critical Care PRN.
• Mojdeh Heavner: Chair, Critical Care PRN.
• Jason Hecht: FCCM – American College of Critical Care Medicine.
• Lauren Igneri: FCCM – American College of Critical Care Medicine.
• Judith Jacobi: Treasurer for the National Coalition for IV Push Safety.
• Michael Kenes:

FCCM – American College of Critical Care Medicine.

Recognitions Committee Chair, Critical Care PRN.

• Kristin Kooda: Research Committee Chair, Critical Care PRN.
• Desiree Kosmisky: FCCM – American College of Critical Care Medicine.
• Robert MacLaren: MCCM – American College of Critical Care Medicine.
• Scott Micek: FCCM – American College of Critical Care Medicine.
• Neha Naik: Residency Program Coordinator and PGY1 Pharmacy Practice Director, Virginia Hospital Center, Arlington, VA.
• Andrea Nei: FCCM – American College of Critical Care Medicine.
• Jerika Nguyen: Communications Committee Chair, Critical Care PRN.
• Keith Olsen: Board Liaison, Critical Care PRN.
• Nicole Palm:

FCCM – American College of Critical Care Medicine.

Member-at-Large, Critical Care PRN.

• Megan Rech:

Associate Editor, American Journal of Health-System Pharmacy.

Pharmacology Associate Editors, Emergency Medicine Reviews and Perspectives (EM:RAP), CorePendium.

• Denise Rhoney: MCCM – American College of Critical Care Medicine.
• Susan Smith:

FCCM – American College of Critical Care Medicine.

Chair of Women Faculty SIG, American Association of Colleges of Pharmacy.

Chair-Elect of Critical Care PRN; Programming Committee Chair, Critical Care PRN.

• Zach Smith: Member-at-Large, Critical Care PRN.
• Louisa Sullivan: Travel Awards Committee Chair, Critical Care PRN.
• Tu-Trinh Tran: PGY2 Critical Care Pharmacy Residency Program Director, Emory University Hospital.
• Corey Witenko: FCCM – American College of Critical Care Medicine.

 

 

 

Promotions

• Andrew Hwang: Associate Professor, MCPHS University – Boston.

 

Publications

• Gonzales S, Okusaga OO, Reuteman-Fowler JC, Oakes MM, Brown JN, et al. Digital medicine system in veterans with severe mental illness: feasibility and acceptability study. JMIR Form Res 2022;6:e34893.
• Goldwire MA, Johnson ST, Abdalla M, Advani A, Bernknopf A, Colella A, Kehr HA, Kier K, May D, May JR, Picone MF, Saad M, Thornby KA, Ward K. Medical misinformation: a primer and recommendations for pharmacists. J Am Coll Clin Pharm 2023. [In press]
• Hwang AY, Cardel MI, Smith SM. Racial and ethnic differences in blood pressure before and after the 2016 United States general election. Am J Hum Biol 2022;34:e23785.
• Bradley CL, McMillin SM, Hwang AY, et al. Tirzepatide, the newest medication for type 2 diabetes: a review of the literature and implications for clinical practice. Ann Pharmacother 2022 Nov 11. [Epub ahead of print]
• Fan M, Yang D, Ng B, Jackson J, Bouris K, Eng S, Rolko E, et al. Impact of technology-assisted versus manual sterile compounding on safety and efficiency in a Canadian community hospital. Am J Health Syst Pharm 2022;79:1685-96.
• Saad M, Rhamtazada M, Chen C, et al. Treatment options for gout. US Pharm 2023;48:37-42.
• Segovia MF, Pallotta AM, Campbell MJ, et al. Impact of a standardized order set and medication-use process on medication error rates in sexual assault patients presenting to the emergency department for HIV nonoccupational postexposure prophylaxis. Am J Health Syst Pharm 2023;80:365-72.

 

 

 

Promotions

• Kelly Covert: Associate Professor of Pharmacy Practice, East Tennessee State University Bill Gatton College of Pharmacy.
• Carinda Feild: Associate Director, Office of Experiential Programs, University of Florida.
• Ashley Higbea:

School of Pharmacy Director of Interprofessional Education.

Associate Professor, Texas Tech University Health Science Center, Jerry H. Hodge School of Pharmacy.

• Trishia E. Shaw: Clinical Associate Professor, Chicago State University College of Pharmacy.

 

Awards

• Paul Boylan:

Teaching and Mentoring Award. ACCP Education and Training PRN. October 2022.

2022 Outstanding Educator. The University of Oklahoma Health Sciences Center College of Pharmacy Department of Pharmacy. August 2022.

Top Poster Award. ACCP Education and Training PRN. July 2022.

Top Poster Award. ACCP Adult Medicine PRN. June 2022.

• Carinda Feild: Teaching and Service Award, University of Florida College of Pharmacy.
• Corey Guidry: Outstanding Adult Medicine Preceptor, OU College of Pharmacy.
• Alex Isaacs:

2022 AACP Emerging Teaching Scholar.

2022 JACCP Outstanding Peer Reviewer.

• Deanna McDanel: Excellence in Innovation Award by the Iowa Pharmacy Association; Sponsored by Upsher-Smith Laboratories, LLC, and the National Alliance of State Pharmacy Associations (NASPA). September 2022.

 

Publications

• Allen JM, Surajbali D, Nguyen D, Kuczek J, Tran M, Hachey B, Feild C, et al. Impact of piperacillin-tazobactam dosing in septic shock patients utilizing real-world evidence: an observational, retrospective cohort study. Ann Pharmacother 2022 Sep 25. [Epub ahead of print]
• Chang F, O’Connell MB, Mills ME, Hwang J, Khreizat HS, Garwood CL, et al. Prevention health medication and behavior outcomes from a brown bag medication review for ambulatory older adults. J Am Geriatr Soc 2022;70:3202-9.
• Cluck D, Covert K, Wagner J, et al. In it for the long-haul: opportunities for clinical pharmacists in the management of post-COVID-19 conditions. J Am Coll Clin Pharm 2022;5:716-24.
• Chastain D, Covert K, Tu P, White B, McDougal S, Cluck D. Therapeutic options for adult patients with persistent methicillin-susceptible Staphylococcus aureus bacteremia: a narrative review. Ann Pharmacother. [In press]
• Elmes AT, Holger D, Cieslak K, Desai D, Kunz Coyne A, Patel V, Rodgers JE, Jarrett JB. Post-graduate pharmacy fellowships: the current state of affairs. J Am Coll Clin Pharm 2023;6:145-53.
• Feild C, Buring S, Whalen K. Using key indicators in pre-APPE performance to predict at-risk students on APPEs. Am J Pharm Educ. [In press]
• Feild C, Miller S, Stultz K, et al. A monitoring and early intervention program at-risk students on advanced pharmacy practice experiences. Am J Pharm Educ 2022 Nov 1. [Epub ahead of print]
• Miller S, Feild C, Phan A. Negative emotional contagion on advanced pharmacy practice experiences: establishing resistance. Am J Health Syst Pharm 2023;80:7-9.
• Guidry CM, Jackson BT, Hawkins WA. Layered learning: eight precepting strategies for the new attending pharmacist. Am J Health Syst Pharm 2022 Dec 26. [Epub ahead of print]
• Hawthorne A, Delgado E, Norton C, et al. Managing acute gastrointestinal bleeds. US Pharm 2022;47:HS1-6.
• Hawthorne A, Walley B, Baral D. An unwelcome guest: the appearance of meropenem-resistant Myroides pneumonia in Mississippi. JMSMA 2023;64(1).
• Speed S, Schneider N, Stutzman SE, Olson DM, Higbea A. Feasibility and efficacy of a nurse practitioner- and pharmacist-led hypertension clinic. J Am Assoc Nurse Pract 2022;34:1045-9.
• Jarrett JB, Elmes AT, Schwartz A. Which entrustment-supervision scale is right for pharmacy education? Am J Pharm Educ. [In press]
• Rohani R, Scheetz MH, Donnelly HK, et al.; NU SCRIPT Study Investigators. Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia. J Antimicrob Chemother 2022;77:2956-9.
• Rhodes NJ, Rohani R, Yarnold PR, et al. Machine learning to stratify methicillin-resistant Staphylococcus aureus risk among hospitalized patients with community-acquired pneumonia. Antimicrob Agents Chemother 2023;67:e0102322.
• Sherrill CH, Lee S. Prevalence, characteristics, and health-related quality of life of continuous glucose monitoring use according to the Behavioral Risk Factor Surveillance System 2014-2020. J Manag Care Pharm. [In press]
• Bradley CL, McMillin SM, Hwang AY, Sherrill CH. Tirzepatide, the newest medication for type 2 diabetes: a review of the literature and implications for clinical practice. Ann Pharmacother 2022 Nov 11. [Epub ahead of print]
• Melendez DR, Bradley CL, Lee S, Sherrill CH. Transition from in-person to telehealth standardized patient encounters: a retrospective analysis of 18 cases. Curr Pharm Teach Learn 2022;14:1518-24.
• Soric MM. Overview of the hematologic system. In: Stuhan MA, ed. Understanding Pharmacology for Pharmacy Technicians, 2nd ed. American Society of Health-System Pharmacists, 2023:537-46.
• Soric MM. Overview of the cardiovascular and renal systems. In: Stuhan MA, ed. Understanding Pharmacology for Pharmacy Technicians, 2nd ed. American Society of Health-System Pharmacists, 2023:281-96.
• Soric MM. Hypertension. In: Stuhan MA, ed. Understanding Pharmacology for Pharmacy Technicians, 2nd ed. American Society of Health-System Pharmacists, 2023:297-316.
• Soric MM. Heart disease. In: Stuhan MA, ed. Understanding Pharmacology for Pharmacy Technicians, 2nd ed. American Society of Health-System Pharmacists, 2023:317-52.
• Soric MM. Hyperlipidemia. In: Stuhan MA, ed. Understanding Pharmacology for Pharmacy Technicians, 2nd ed. American Society of Health-System Pharmacists, 2023:353-65.
• Soric MM. Study designs: design and application. In: Bernhardt MB, Blackmer A, Cho HJ, et al., eds. Updates in Therapeutics^®: Pediatric Pharmacy Preparatory Review and Recertification Course, 2022 ed. American College of Clinical Pharmacy, 2022:827-56.
• Starr JA, Pinner NA, Manis M, et al. A review of direct oral anticoagulants in patients with stage 5 or end-stage kidney disease. Ann Pharmacother 2022;56:691-703.
• Starr JA, Trott V. Medications when the brain hurts. Physician Assistant Clinics 2022. [Epub ahead of print]
• Downey J, Blackwell S, Germain K, Pinner NA, Starr JA. Dual antiplatelet therapy after an acute non-minor stroke. J Pharm Technol 2023. [In press]
• Osmonson A, Pinner NA, Starr JA. Warfarin or non-vitamin K antagonists for atrial fibrillation in end-stage kidney disease. South Med J 2022;115:794-8.
• Pinner NA, Starr JA, Lisenby KM. Impact of evidence-based pharmacotherapy (EBP) elective course on fourth year students’ performance. Pharm Educ 2022;22:498-502.
• Ho TT, Noble M, Tran BA, et al. Clinical impact of the CYP2C19 gene on diazepam for the management of alcohol withdrawal syndrome. J Pers Med 2023;13:285.
• Vordenberg SE, Maitah Y, Khan Z, et al. Consumer perceptions of the OTC Coach, a clinical decision support system aimed at improving the safe use of over-the-counter medications. J Am Pharm Assoc 2023;63:135-43.
• Vordenberg SE, Weir K, Jansen J, et al. Harm and medication-type impact agreement with hypothetical deprescribing recommendations: a vignette-based experiment with older adults across four countries. J Gen Intern Med Nov 14. [Epub ahead of print]
• Maitah Y, Rana R, Vordenberg SE. Older adults experiencing polypharmacy preferred to continue their nonprescription products during a card sorting activity. Int J Pharm Pract 2022 Dec 19. [Epub ahead of print]
• Maranets M, Harmer K, Vordenberg SE, et al. Pre-visit planning calls conducted by student pharmacists in a student-run free clinic. J Student Run Clin 2022;8:1-6.

 

Presentations

• Boylan P:

Updates in allergic rhinitis and conjunctivitis: when to recommend the new Rx-to-OTC switches. Presented at: Walter P. Scheffe Continuing Pharmaceutical Education Series; October 2022, Oklahoma City, OK.

Building a better tomorrow with your colleges of pharmacy. Presented at: National Association of Boards of Pharmacy Districts 6, 7, 8 Meeting; August 2022, Oklahoma City, OK.

• Elmes AT, Allen SA, Djuric Kachlic M, Schriever A, Driscoll TP, Jarrett JB. Perspectives of advanced pharmacy practice experience preceptors for utilizing entrustable professional activity frameworks within learner assessments. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Elmes AT, Koronkowski M, Leung V, Andes S, Jarrett JB. Exploring prescriber perspectives on opioid education and naloxone access in older adults in the urban setting. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Elmes AT, Schwartz A, Tekian A, Jarrett JB. Evaluating the quality and structure of the core entrustable professional activities for new pharmacy graduates. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Elmes AT, Yoshihara J, Allen SA, Djuric Kachlic M, Driscoll TP, Choye M, Kucher O, Jarrett JB. Utilization of entrustable professional activities in a skills-based course to develop reflective learning skills: a 3-year analysis. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Guidry C. Old DOACs, new tricks. Presented at: Oklahoma Society of Health-System Pharmacists 2022 Fall Meeting; September 2022; Broken Arrow, OK.
• Infante A, Keller E, Messmer S, Elmes AT, Jarrett JB. Implementation of a pharmacist-driven opioid use disorder medication assisted recovery (OUD MAR) inpatient consult service. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Jarrett JB, Keller E, Elmes AT, et al. Quick, to the BupMobile: describing an interprofessional primary care mobile unit for substance use disorder treatment in underserved populations. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• McDanel D, Greiner S. Change is inevitable: updates in the management of anticoagulation therapy. Presented at: PharmaCE Expo hosted by the Iowa Pharmacy Association; February 2023; Des Moines, IA.
• McQuade BM, Keller E, Elmes AT, DiDomenico R, Jarrett JB. Stratification of burnout in health-system pharmacists during the COVID-19 pandemic: a focus on the ambulatory care pharmacist. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• O’Connell MB. Bone up on what’s new in osteoporosis prevention and treatment. Presented at: ASHP Midyear Clinical Meeting; December 2022; Las Vegas, NV.
• Rohani R. Population pharmacokinetics and target attainment rates among meropenem-treated patients admitted to the intensive care unit with hospital-acquired pneumonia. Presented at: Illinois Council of Health-System Pharmacists Annual Meeting (Pharmacy Practice Session); September 2022; Oakbrook Terrace, IL.
• Sherrill C. Effect of pharmacist-driven continuous glucose monitoring in adults with uncontrolled diabetes. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Slampak-Cindric A:

Microaggressions: what can you do? Presented at: National Pharmacy Preceptor’s Conference; October 2022; Chicago, IL.

Anticoagulation in adult ECMO: time in therapeutic range with heparin or bivalirudin. Presented at: Society of Critical Care Medicine Congress. January 2023; San Francisco, CA.

• Soric MM. Study designs: design and application. Presented at: ACCP Updates in Therapeutics^®: Pediatric Pharmacy Preparatory Review and Recertification Course Webinar; December 2022; virtual.
• Hardrick C, Osmonson A, Starr JA. Assessment of heparin twice daily versus three times daily for venous thromboembolism prevention. Presented at: ASHP Midyear Clinical Meeting; December 2022; Las Vegas, NV.
• Hattaway Q, Jackson C, Carswell K, Pinner NA, Starr JA. Direct oral anticoagulants for the treatment of venous thromboembolism in obesity. Presented at: ASHP Midyear Clinical Meeting; December 2022; Las Vegas, NV.

 

Other Notable Achievements

• Abigail Elmes: Master of Health Professions Education (MHPE) from the University of Illinois Chicago College of Medicine, Department of Medical Education.
• Jennie Jarrett: BCACP
• Trishia Shaw: BCACP

 

 

 

Members of the EMED PRN have been involved in several prestigious awards and publications. The PRN has continued to host journal club webinars from pharmacy residents and students across the country. The monthly journal clubs have continued to host two presenters each month, and attendance has continued to increase. The EMED PRN has an active Twitter presence with a following now exceeding 4750.

 

Promotions

• Lauren Beauchamp: PGY1 Pharmacy Residency Program Director, Franciscan Health Indianapolis, Indianapolis, IN.
• Andrew P. Smith: PGY2 Emergency Medicine Pharmacy Residency Program Director, Scripps Mercy Hospital, San Diego, CA.

 

Awards

• Lisa Hayes: Power of One Award, Methodist University Hospital, Memphis, TN.
• Andrew P. Smith: Preceptor of the Year, Scripps Mercy Hospital, San Diego, CA.

 

Grants

• Jessica D. Woodward: Epinephrine Autoinjectors for Emergency Department Patients at Discharge: A Quality Improvement Project. The White Rose Giving Circle ($8544).

 

Publications

• Acquisto NM, Cushman JT, Johnston M, et al. Prehospital medicine learning experience for pharmacy residents. J Am Coll Clin Pharm 2023;6:111-6.

• Acquisto NM, Uttaro E, Debona D, Minhaj FS. Assessment of rabies immune globulin dose rounding at a university health system. Am J Emerg Med 2022;58:141-7.
• Bajdas H, Handzel M, Uttaro E, Jones CMC, Kokanovich K, Acquisto NM. Evaluation of fixed-dose versus variable-dose prothrombin complex concentrate for warfarin reversal. Thromb Res 2022;214:76-81.
• Frohnapple C, Acquisto NM, Nobay F. Barbiturates. In: Wexler P, ed. Encyclopedia of Toxicology, 4th ed., vol 1. Elsevier, 2022.
• Groth CM, Acquisto NM, Wright C, et al. Pharmacists as members of an interdisciplinary pulmonary embolism response team. J Am Coll Clin Pharm 2022;5:390-7.
• Groth CM, Droege CA, Connor KA, Kaukeinen K, Acquisto NM, et al. Multicenter retrospective review of ketamine use in the intensive care unit (Ketamine-ICU Study). Crit Care Explor 2022;4:e0633.
• Pillinger K, Treptow C, Dick TB, Jones CMC, Acquisto NM. Development and implementation of pharmacy department and pharmacy resident well-being programs. Am J Health Syst Pharm 2022;79:1337-44.
• Sacdal JPA, Cheon E, Stilwell AM, Acquisto NM, et al. Oritavancin versus oral antibiotics for treatment of skin and skin structure infections in the emergency department. Am J Emerg Med 2022;60:223-4.
• Schult RF, Nacca N, Grannell TL, Jorgensen RM, Acquisto NM. Evaluation of high-dose insulin/euglycemia therapy for suspected β-blocker or calcium channel blocker overdose following guideline implementation. Am J Health Syst Pharm 2022;79:547-55.
• Booth DY, Amalfitano C, Forestine A. Changes in opioid prescription rates at discharge after targeted provider education in the emergency department. J Pharm Pract 2022 Nov 13.

• Kelly G, Branstetter L, Moran T, Hanzelka N, Cooper C. Low- versus high-dose nitroglycerin infusion in the management of acute pulmonary edema. Am J Emerg Med 2022;65:71-5.

• Minhaj FS, Carranza D, Adeyemo A, et al. The Epidemic Intelligence Service: an exciting opportunity for pharmacists to improve population health. J Am Pharm Assoc (2003) 2022;62:913-4.
• Minhaj FS, Ogale YP, Whitehill F, et al.; Monkeypox Response Team 2022. Monkeypox outbreak – nine states, May 2022. MMWR Morb Mortal Wkly Rep 2022;71:764-9.
• Minhaj FS, Petras JK, Brown JA, et al.; CDC Monkeypox Emergency Response Team. Orthopoxvirus testing challenges for persons in populations at low risk or without known epidemiologic link to monkeypox – United States, 2022. MMWR Morb Mortal Wkly Rep 2022;71:1155-8.
• Minhaj FS, Rao AK, McCollum AM. Imported monkeypox from international traveler, Maryland, USA, 2021. Emerg Infect Dis 2022;28:1738.
• Blackburn D, Minhaj FS, Al Hammoud R, et al. Human rabies – Texas, 2021. MMWR Morb Mortal Wkly Rep 2022;71:1547-9.
• Gigante CM, Korber B, Seabolt MH, Wilkins K, Davidson W, Rao AK, Zhao H, Smith TG, Hughes CM, Minhaj F, et al. Multiple lineages of monkeypox virus detected in the United States, 2021-2022. Science 2022;378:560-5.
• Hennessee I, Shelus V, McArdle CE, Wolf M, Schatzman S, Carpenter A, Minhaj FS, et al.; California Department of Public Health Monkeypox Pediatric Working Group; CDC Monkeypox Pediatric Working Group. Epidemiologic and clinical features of children and adolescents aged <18 years with monkeypox – United States, May 17-September 24, 2022. MMWR Morb Mortal Wkly Rep 2022;71:1407-11.
• Miller MJ, Cash-Goldwasser S, Marx GE, Schrodt CA, Kimball A, Padgett K, Noe RS, McCormick DW, Wong JM, Labuda SM, Borah BF, Zulu I, Asif A, Kaur G, McNicholl JM, Kourtis A, Tadros A, Reagan-Steiner S, Ritter JM, Yu Y, Yu P, Clinton R, Parker C, Click ES, Salzer JS, McCollum AM, Petersen B, Minhaj FS, et al.; CDC Severe Monkeypox Investigations Team. Severe monkeypox in hospitalized patients – United States, August 10 – October 10, 2022. MMWR Morb Mortal Wkly Rep 2022;71:1412-7.
• Pfeiffer JA, Collingwood A, Rider LE, Minhaj FS, et al. High-contact object and surface contamination in a household of persons with monkeypox virus infection – Utah, June 2022. MMWR Morb Mortal Wkly Rep 2022;71:1092-4.
• Rao AR, Schrodt CA, Minhaj FS, et al. Interim clinical treatment considerations for severe manifestations of Mpox – United States, February 2023. MMWR Morb Mortal Wkly Rep 2023 Feb 24.
• Weant KA, Acquisto NM, Doyno CR, et al. Development of an emergency medicine pharmacy intensity score tool. Am J Health Syst Pharm 2023;80:215-21.
• Weant KA, Clendening AM, Bush JS. A case report of hypoglycemia following a tramadol overdose in a non-diabetic patient. J Pharm Pract 2022;35:661-3.
• Preheim EA, Phillips CM, Weant KA. Latex allergy alerts in the age of CPOE: assessing the risk from injectable medications. Hosp Pharm 2022;57:413-5.

 

Other Notable Achievements

• Andrew P. Smith:

Graduate, 2022 ACCP Leadership Academy.

President, San Diego Society of Health-System Pharmacists.

• Kyle Weant: 2022 Journal of the American College of Clinical Pharmacy (JACCP) Outstanding Reviewer.

 

Presentations

• Nicole Acquisto:

Manuscript development. Presented at: ASHP Research Skills Certificate Program; 2022.

Impact of clinical services on ED patient outcome. Presented at: King Hussein Cancer Center, Al-Jubeiha, Amman, Jordan, 2022 (Part of the SCCM CPP Visiting Clinical Professors Program).

• Deborah Booth:

Appropriate opiate: the tale of the serious pain killers. Presented at: NJSHP Monthly Chapter Meeting; November 2022; virtual.

Updates in anticoagulation reversal. Presented at: Atlantic Health System APN Council; December 2022. In person/virtual platform continuing education program, Summit, NJ.

Augmentin your antibiotic knowledge. Presented at: Atlantic Health System APN Council; September 2022. In person/virtual platform continuing education program; Summit, NJ.

Pharmacy jeopardy. Presented at: Medical Resident Academic-Half Day; February 2023; Summit, NJ.

Rapid sequence intubation: Pokémon GO edition. Presented at: Medical Resident Academic-Half Day; October 2022; Summit, NJ.

Surviving sepsis and sepsis escape room. Presented at: Medical Resident Academic-Half Day; September 2022; Summit, NJ.

Sepsis and antibiotics pharmacotherapy. Presented at: Seton Hall University, South Orange, NJ to APN students; September 2022; virtual.

Residency, requirements, and resiliency. Presented at: NJPhA Annual Meeting; October 2022; Princeton, NJ. In-person presentation for pharmacy student track.

• Andrew P. Smith:

BCPS/BCCCP intensive review – The beast in the belly: complications and management of liver failure. Presented at: ASHP Midyear Clinical Meeting; December 2022; Las Vegas, NV.

TEG Talk – Thromboelastography primer for pharmacists. Presented at: California Society of Health-System Pharmacists Annual Seminar; November 2022; Anaheim, CA.

ASHP/ACCP BCEMP review course – Complex case: hepato-GI. Presented at: ASHP/ACCP Emergency Medicine Pharmacy Specialty Certification Review Course; 2022; virtual.

• Kyle Weant:

Considerations for interventional research. Presented at: ASHP Research Skills Certificate Program; 2022; virtual.

Grant funding and writing. Presented at: ASHP Research Skills Certificate Program; 2022; virtual.

Identifying and addressing bias in research. Presented at: ASHP Research Skills Certificate Program; 2022; virtual.

Introduction to results interpretation. Presented at: ASHP Research Skills Certificate Program, 2022; virtual.

 

 

 

Promotions/Leadership

• Sara Lingow:

Assistant Professor of Pharmacy Practice, St. Louis College of Pharmacy at UHSP, St. Louis, MO.

ACCP Ambulatory Care PRN Networking Committee Chair 2023.

• Sylvia Ou: Clinical Pharmacy Specialist – Ambulatory Care, Rush University Medical Center, Chicago, IL.

• Christie Schumacher: Chair, BPS Ambulatory Care Council.

 

Awards

• Diana Isaacs: Southern Illinois University Edwardsville Hall of Fame Inductee.
• Heather P. Whitley: Honorable Mention. Auburn University Outreach Award. Beyond Auburn. Winter 2022 newsletter.

 

Grants

• Sara Lingow: ACCP Ambulatory Care PRN Seed Grant Recipient 2021.

 

Publications

• Albanese NP. Systemic lupus erythematosus. In: Schwinghammer TL, Koehler JM, Borchert JS, et al., eds. Pharmacotherapy Casebook: A Patient-Focused Approach, 12th ed. McGraw-Hill, 2023.
• O’Brocta R, Albanese NP. Student self-evaluation of professionalism during advanced pharmacy practice experiences. Pharm Educ 2023;23:1-6.
• Goldman JD, Angueira-Serrano E, Gonzalez J, et al. Survey reveals patient and health care provider experiences and challenges with the use of high doses of basal insulin. Clin Diabetes 2022 Dec 6. [Epub ahead of print]
• Goldman JD, Dvorkin Camiel L. A new medical probiotic formulation for the management of type 2 diabetes. Clin Diabetes 2022;40:500-2.
• Goldman JD, Sangave N. Misdiagnosis of type 1 diabetes identified at a primary care pharmacist visit. Clin Diabetes 2022 Nov 10. [Epub ahead of print]
• Brunton S, Fishbane S, Goldman JD, et al. Anemia in CKD in primary care: executive summary. Clin Diabetes 2023;41:81-4.
• Choi H, Goldman J. Effects of antidiabetic medications on the risk of bone fracture in patients with type 2 diabetes mellitus. ADCES Pract 2022;10:10-4.
• Martinez A, Goldman JD. Efficacy and durability of combination treatment with glucagon-like peptide-1 receptor agonists and basal insulin. ADCES Pract 2022;10:42-5.
• Prisco JL, Goldman JD, Eguale T, et al. Important factors in remote experiential education. Pharmacy 2022;10:122.
• Hess R, Schumacher C, Whitley HP, Reece S, Knezevich EL, Dela Pena LE, Gross B, Knezevich JT, Ginzburg R, Albanese NP, Isaacs D. Diabetes technology: a primer highlighting the role of the pharmacist. J Am Coll Clin Pharm 2022;5:1307-23.
• Hess R, Whitley HP, Majerczyk D, Stamm P. An online, multi-institutional debate on diabetes medications by advanced pharmacy practice experience students. Am J Pharm Educ 2023;87:ajpe8815.
• Isaacs D, Mobley-Bukstein W. Part five: the role of deprescribing and adjusting glycemic targets in older people with diabetes. Sr Care Pharm 2022;37:384-93.
• Nallicheri A, Mahoney KM, Gutow HA, Bellini N, Isaacs D. Review of automated insulin delivery systems for type 1 diabetes and associated time in range outcomes. touchREV Endocrinol 2022;18:27-34.
• Phillip M, Nimri R, Bergenstal RM, Barnard-Kelly K, Danne T, Hovorka R, Kovatchev BP, Messer LH, Parkin CG, Ambler-Osborn L, Amiel SA, Bally L, Beck RW, Biester S, Biester T, Blanchette JE, Bosi E, Boughton CK, Breton MD, Brown SA, Buckingham BA, Cai A, Carlson AL, Castle JR, Choudhary P, Close KL, Cobelli C, Criego AB, Davis E, de Beaufort C, de Bock MI, DeSalvo DJ, DeVries JH, Dovc K, Doyle FJ, Ekhlaspour L, Shvalb NF, Forlenza GP, Gallen G, Garg SK, Gershenoff DC, Gonder-Frederick LA, Haidar A, Hartnell S, Heinemann L, Heller S, Hirsch IB, Hood KK, Isaacs D, et al. Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. Endocr Rev 2023;44:254-80.
• Zhou K, Isaacs D. Closed-loop artificial pancreas therapy for type 1 diabetes. Curr Cardiol Rep 2022;24:1159-67.
• Schumacher C. Severe hypotension with concomitant sodium-glucose co-transporter-2 inhibitor and angiotensin receptor-neprilysin inhibitor therapy in a patient with heart failure reduced ejection fraction: a case report. J Pharm Pract 2022;8971900221142686.
• Van Dril E, Schumacher C. Chronic kidney disease in people with diabetes. In: Sanoski CA, Witt DM, eds Pharmacotherapy Self-Assessment Program. 2023 Book 1. Endocrinology and Nephrology. American College of Clinical Pharmacy, 2023:7-35.
• Banjara B, Poudel N, Garza KB, Westrick S, Whitley HP, et al. Patients’ preferences for sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists. Patient Prefer Adherence 2022;16:3415-28.
• Blaine E, Tumlinson R, Colvin M, Haynes T, Whitley HP. Systematic literature review of insulin dose adjustments when initiating hemodialysis or peritoneal dialysis. Pharmacotherapy 2022;42:177-87.
• Novak J, August KJ, Kavookjian J, Whitley HP, et al. Exploring typologies of appraisals, involvement, and distress in type 2 diabetes family members. J Health Psychol 2023;28:133-48.

 

Presentations

• Nicole Albanese: Updates in diabetes. Presented at: 2022 ACCP-Taiwan Virtual Pharmacotherapy Symposium; September 2022; virtual.
• Sarah L. Anderson:

Illuminating the patient perspective: what healthcare professionals should know about living with nontuberculous mycobacterial lung disease. Presented at: CHEST 2022 Meeting; October 2022; Nashville, TN.

Getting to the heart of the matter: race-based medicine in cardiovascular disease. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

A novel educational program to address misunderstandings in applying AASLD HBV treatment guidelines. Poster presented at: AASLD “The Liver Meeting”; November 2022; Washington, DC.

• Sarah L. Anderson, Joel C. Marrs: Cardiovascular disease risk management for people living with mental illness. Presented at: Colorado Pharmacists Society Winter Meeting; January 2023; Beaver Creek, CO.
• Hess R, Schumacher C, Whitley HP, Reece S, Knezevich E, Dela Pena LE, Gross B, Knezevich J, Ginzburg R, Albanese N, Isaacs DM. Opinion paper from Endocrine and Metabolism PRN on diabetes technology & role of the pharmacist. Poster presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Kim Kelly: Diabetes and gut health: from pathophysiology to use of various biotics. Presented at: ADCES 2022; Platform presentation; August 13, 2022; Baltimore, MD.
• Lingow S: Evaluation of student peer- and self-grading in an integrated pharmacotherapy course. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Sylvia Ou: Aspirin deprescribing in patients on oral anticoagulation for atrial fibrillation or venous thromboembolism: a national survey of clinician practices. Poster presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Sara (Mandy) Reece: Weight management: one size does not fit all. Presented at: ASHP Midyear Clinical Meeting; December 2022; Las Vegas, NV.
• Christie Schumacher: The prevention and management of heart and kidney disease in people with diabetes. Presented at: Association of Diabetes Care and Education Specialists Live Webinar; virtual.
• Christie Schumacher and Liz Van Dril: Building the case for SGLT2 inhibitors in diabetes-related CKD. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Heather P. Whitley:

Diabetes: identifying and educating high-risk individuals. Presented at: Medavera; On Medical Grounds; November 2022; podcast.

Association between diabetes management and family members’ psychosocial and physical health during the COVID-19 pandemic. Poster presented at: ADCES22; August 2022; Baltimore, MD.

 

New ACCP Fellows

• Heather P. Whitley

 

Other Notable Achievements

• Sylvia Ou: BCACP
• Heather P. Whitley: Initiated into Zeta Chapter, Pharmaceutical Honor Society Rho Chi, Auburn University, Harrison College of Pharmacy. September 2022.

 

 

 

Promotions

• Ashley Higbea: SOP Director of Interprofessional Education and Associate Professor, Texas Tech University Health Science Center, Jerry H. Hodge School of Pharmacy.

 

Awards

• Linda Sobeski: Chancellor’s Silver “U” Award, University of Nebraska Medical Center.

 

Grants

• Collin Clark: A Pilot Pharmacist-to-Pharmacist Hand-off Intervention During Transitions of Care. American Association of Colleges of Pharmacy New Investigator Award. Principal Investigator ($7500).
• Jeannie Lee: ACOA/MSTEM THRIVE Program for Undergraduates. NIH-NIA R25 ($1,835,349).
• Sharon See: Promoting Healthy Aging Among WTC Responders: Frailty Trajectories and Intervention Strategies. CDC/National Institute for Occupational Safety and Health (NIOSH) UO1. Sub-Principal Investigator ($84,857).

 

Publications

• Lee JK, Collins BK, Pepper E, et al. Improving a leadership scale: applying Rasch analysis to student pharmacists’ attitudes and beliefs about leadership. Am J Pharm Educ 2022. [Epub ahead of print]
• Marupuru S, Arku D, Campbell AM, Slack MK, Lee JK. Use of melatonin and/or ramelteon for the treatment of insomnia in older adults: a systematic review and meta-analysis. J Clin Med 2022;11:5138-53.
• Vadiei N, Lee JK. An innovative approach to teaching depression/anxiety medication management: virtual choose your own adventure, psychiatry edition. Ment Health Clin 2022;12:225-31.
• Chang F, O’Connell MB, Mills ME, et al. Prevention health medication and behavior outcomes from a brown bag medication review for ambulatory older adults. J Am Geriatr Soc 2022;70:3202-9.

 

Other Notable Achievements

• Hedva Barenholtz Levy:

Maybe It’s Your Medications: How to Avoid Unnecessary Drug Therapy and Adverse Drug Reactions. Skyhorse Publishing, scheduled for publication in late May 2023.

Chair of the Board, American Society of Consultant Pharmacists.

 

 

 

Publications

• Chapman A, Yerke J, Rudoni M, Militello M, Lumpkin M, Wang L, Bass S. Evaluation of response to high-dose intravenous vitamin K administration. Ann Pharmacother 2023 Feb 20. [Epub ahead of print]
• White S, Morrow R, Pan I, et al. Riding the wave of adalimumab biosimilars: considerations for pediatric gastroenterologists. J Pediatr Gastroenterol Nutr 2023 Mar 6. [Epub ahead of print]

 

Presentations

• Kelsey Rife: Engaging your residency preceptors. Presented at: Ohio College of Clinical Pharmacy Fall Meeting; October 2022; Warrensville Heights, OH.
• Maria Sheridan: Biosimilars: production to patient – general considerations in practice. Presented at: Rheumatology Nurses Society Virtual Fall Summit; November 2022; virtual.
• Sally Tice:

Optimization of glycemic management in patients receiving parenteral nutrition. Presented at: ASHP Midyear Clinical Meeting; December 2022; Las Vegas, NV.

Evaluation of enteral and parenteral protein nutrition in trauma patients. Presented at: ASHP Midyear Clinical Meeting; December 2022; Las Vegas, NV.

 

New ACCP Fellows

• Angela Bingham
• Jenna Lovely

 

Other Notable Achievements

• Joe Ybarra: Master of Science in Healthcare Administration, Texas Tech University, December 2022.

 

 

 

Promotions

• Lauren Jonkman: Associate Professor, Department of Pharmacy Practice and Policy, School of Pharmacy University of Namibia Faculty of Health Sciences and Veterinary Medicine.

 

Grants

• Lauren Jonkman, Sharon Connor: Envisioning Health Justice Through Photovoice: Engaging Health Science Students in Structural Competency. University of Pittsburgh Provost’s Advisory Council on Instructional Excellence Innovation in Education Award. Primary Investigator (Jonkman), Co-Investigator (Connor) ($5000).
• Pavel Prusakov: Antibiotic Use Among Surgical Patients in the Neonatal Intensive Care Unit (NICU): The NO-More-AntibioticS and Resistance in Surgery (NO-MAS-R-S) Study. Funding agency: Merck.
• Melody Ryan: Improving Health Care and Diplomacy in Ecuador with University of Kentucky Shoulder to Shoulder Global USAID-ASHA. Co-Investigator ($421,681).
• Tina Tran: Community Engagement to Reduce Disparities and Improve Immigrant Health in North Philadelphia (Funding agency: Temple University Office of the Provost). Project run jointly by the Temple University School of Pharmacy and Temple University College of Public Health. Co-Primary Investigator.

 

Publications

• Lin YT, Chu CY, Hung KS, Lu CH, Bednarczyk EM, Chen HY. Can machine learning predict pharmacotherapy outcomes? An application study in osteoporosis. Comput Methods Programs Biomed 2022;225:107028.
• Lu YT, Chao HJ, Chiang YC, Chen HY. Explainable machine learning techniques to predict amiodarone-induced thyroid dysfunction risk: multicenter, retrospective study with external validation. J Med Internet Res 2023;25:e43734.
• Karwa R, Schellhase E, Malati C, Pastakia S, Manji I, Samuel J, Miller M. Implementation of a Global Health Equity fellowship established in partnership between an academic institution and governmental agency. J Am Coll Clin Pharm 2023;6:135-44.
• Teklu Y, Monangai KE, Abdul-Mutakabbir JC, et al. Promoting health equity in pharmacy postgraduate training programs: a call to action for clinical pharmacists. J Am Coll Clin Pharm 2023;6:165-70.
• Prescott GM, Jonkman L, Crutchley RD, et al. Characteristics of successful international partnerships. Pharmacy (Basel) 2023;11:7.
• Sánchez P, Prusakov P, de Alba Romero C, et al. Short-course empiric antibiotic therapy for possible early-onset sepsis in the NICU. J Perinatol 2023 Feb 22. [Epub ahead of print]
• Rotundo HW, Connor SE, Muzzio KB, Taylor AM, Meyer MW, Jonkman LJ. Impact of an international service trip on pharmacy and medical learners’ attitudes toward interprofessional collaboration. Am J Pharm Educ 2022;86:8748.
• Rotundo HW, Horace AE. Chronic asthma. In: Matthias KR, Katz MD, eds. Pharmacotherapy Principles and Practice Study Guide: A Case-Based Care Plan Approach, 6th ed. McGraw-Hill Medical, 2023.
• Ryan M. The #RxWritingChallenge: a way to boost productivity and camaraderie and overcome writing barriers. A programme description and quality improvement survey. Pharm Educ 2022;22:95-9.
• Forrest J, Elnaem MH, Gleason SE, Birnie C, Ryan M. White paper on the scholarship of teaching and learning: expanding the academic pharmacy promotion and tenure process. Pharm Educ 2022;22:115-22.
• Tran DN, Ching J, Kafu C, Wachira J, Koros H, Venkataramani M, Said J, Pastakia SD, et al. Interruptions to HIV care delivery during pandemics and natural disasters: a qualitative study of challenges and opportunities from frontline healthcare providers in western Kenya. J Int Assoc Provid AIDS Care 2023;22:23259582231152041.

 

Presentations

• Jonkman L:

Use of a Delphi approach to identify skills and qualities essential for international pharmacy practice experiences. Presented at: International Pharmaceutical Federation World Congress; September 2022; Seville, Spain.

Quality of diabetes care at a district hospital in Namibia. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

Effectiveness of post-operative pain management among surgical patients in Namibia. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

• Jonkman L, Connor S: Increasing vaccine access among uninsured patients at a free clinic. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Jonkman LJ, Crowe S: Global Health PRN Focus Session: Non-communicable disease management at the last mile, where global meets local. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Jonkman L, Prescott G: Characteristics of successful international partnerships based on the five pillars of global health engagement. Presented at: International Pharmaceutical Federation World Congress; September 2022; Seville, Spain.
• Ryan M:

Pharmaceutical care in the United States. Presented at: National Conference Medical Review in Pharmacy and Hospital Ward; November 2022; virtual.

Evolution of interprofessional short-term experiences in global health in under-resourced regions of Ecuador: a University of Kentucky and Shoulder to Shoulder collaboration. Presented at: Nexus Summit 2022; September 2022; virtual.

Pharmacologic management of Parkinson’s disease. Presented at: Parkinson’s Foundation Comprehensive and Equitable Care for People with Parkinson’s by Community Providers virtual course; September 2022; virtual.

Expanding to new frontiers in APPEs with technology. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

• Schellhase E, Jonkman L, Connor S, Ryan M: The impact of an international experience on career development of student pharmacists. Presented at: International Pharmaceutical Federation World Congress; September 2022; Seville, Spain.

 

New ACCP Fellows

• Gina Prescott

 

 

 

The Health Equity PRN wishes to congratulate its members on their accomplishments last year. We look forward to implementing our educational, research, and mentorship initiatives. As the PRN expands, we look forward to opportunities to collaborate and more ways to engage our members. Please reach out to us if you have any questions or ideas to promote health equity in our profession.

 

Awards

• Jerika Nguyen: Presidential Citation Award, Society of Critical Care Medicine.

 

Grants

• Faria Chaudhry:

Evaluating the impact of a community health worker for diabetes management in self-employed women in India. Women’s Global Health Institute & Indiana Clinical and Translational Science Institute Purdue. Principal Investigator ($15,000).

Indianapolis Working Hungry Mini Grant – Documentary Grant. Indy Working Hungry. Lead Manager ($500).

Assessing the Impact of Online Education Access in the Homeless Through a Pharmacist-Led Approach, Francke Grant. Purdue. Principal Investigator ($7500).

• Shawn Smith: Test to Treat Equity Grant. Symba Center. Principal Investigator ($423,000).

 

Publications

• Adeoye-Olatunde OA. Advancing pharmacy technician roles in addressing social determinants of health. J Am Pharm Assoc 2023;63:3-4.
• Waghmare PH, Huang CY, Jaynes HA, Green WM, Snyder ME, Adeoye-Olatunde OA, et al. Disparities in Medicare beneficiaries’ receiving medication synchronization. J Am Pharm Assoc 2022 Oct 22. [Epub ahead of print]
• Astle KN, Mills AR, Medlin CG. Breaking the ice: creating and maintaining an affirming practice setting for LGBTQIA+ pharmacy trainees. J Am Coll Clin Pharm 2023;6:43-8.
• Cottino MC, Kulig CE, Suh JS, Jimenez HR. Evaluation of statin prescribing practices and predictors of statin underutilization in persons with HIV. J Acquir Immune Defic Syndr 2023;92:334-9.
• Greer D, Parikh A, Jimenez HR. Readmission rates of patients discharged on antipsychotic polypharmacy compared to antipsychotic monotherapy. Community Ment Health J 2023;59:507-11.
• Teklu Y, Monangai KE, Abdul-Mutakabbir JC, Gosser RA. Promoting health equity in pharmacy postgraduate training programs: a call to action for clinical pharmacists. J Am Coll Clin Pharm 2023;6:165-70.
• Osae SP, Chastain DB, Young HN. Access to media and emerging technologies: an evolving opportunity for pharmacists to contribute to improving health outcomes. J Pharm Pract 2023 Jan 5. [Epub ahead of print]
• Chastain DB, Patel VS, Jefferson AM, Osae SP, et al. Distribution of age, sex, race, and ethnicity in COVID-19 clinical drug trials in the United States: a review. Contemp Clin Trials 2022;123:106997.
• Miller JA, Lavender DL, Johnson BR, Osae SP, et al. Factors associated with pharmacy residency matching: a scoping review. J Am Coll Clin Pharm 2023;6:171-85.
• Rawal S, Osae SP, Cobran EK, et al. Pharmacists’ naloxone services beyond community pharmacy settings: a systematic review. Res Social Adm Pharm 2023;19:243-65.
• Ho TT, Noble M, Tran BA, et al. Clinical impact of the CYP2C19 gene on diazepam for the management of alcohol withdrawal syndrome. J Pers Med 2023;13:285.

 

Presentations

• Omolola A. Adeoye-Olatunde:

Journey toward social impact through community-based health services. Invited speaker. Presented at: Lead Forward Luminary Event; February 2023; West Lafayette, IN.

The road less traveled: establishing a health equity research institute within a college of pharmacy program. Invited speaker. Presented at: American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

Healthcare Panel – Older adult safety and wellness during the pandemic. Invited panelist. Presented at: CICOA Aging Advantages Faith Summit; October 2022; Indianapolis, IN.

Health Equity Council – A community health worker workforce development update. Invited speaker. Presented at: Minority Health Partners Conference; September 2022; Indianapolis, IN.

Engaging community health workers (CHWs) in research to advance health equity. Invited speaker. Presented at: Regenstrief Center for Healthcare Engineering Summit; September 2022; West Lafayette, IN.

Barriers, facilitators, and recommendations for implementing health information exchange in community pharmacies. Poster presented at: Academy Health Annual Conference on the Science of Dissemination and Implementation; December 2022; Washington, DC.

What predicts older adults’ self-reported medication deprescribing behaviors? The intertwined roles of social determinants of health and health beliefs. Poster presented at: Purdue University College of Pharmacy Research Day; November 2022; West Lafayette, IN.

Meeting people where they are: a novel naloxone distribution program offered at food pantries and homeless shelters. Poster presented at: National Harm Reduction Conference; October 2022; San Juan, Puerto Rico.

A developmental, formative evaluation to inform implementation of bidirectional health information exchange in community pharmacies. Poster presented at: Indiana Clinical and Translational Sciences Institute Annual Meeting; September 2022; Indianapolis, IN.

Development of a social determinants of health (SDOH)-centered adapted Pharmacists’ Patient Care Process (PPCP). Poster presented at: Regenstrief Center for Healthcare Engineering Summit; September 2022; West Lafayette, IN.

• Sally Arif:

Patient-centered cultural care: a focus on health beliefs and practices. Presented at: IVPN Global Health Meeting; February 2023.

It’s not enough to just be ethical, we also need to be socially responsible and equitable. Invited presentation at: FIP World Congress; 2022; Seville, Spain.

Shared decision making: how do we ensure culturally appropriate information and services? Invited presentation at: FIP World Congress; 2022; Seville, Spain.

The pharmacist’s role to advance health equity and advocate for justice. Invited keynote. Presented at: Michigan Society of Health-System Pharmacists (MSHP) Annual Meeting; October 2022.

• Sharmon P. Osae:

Kenneth L. Waters Lecture: Exploring the impact of the COVID-19 pandemic on the future of the pharmacy profession. Panelist presented at: UGA COP. November 2022; Athens, GA.

Getting uncomfortable: incorporating health equity into experiential education. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

Evaluation of quality measure attainment with pharmacist-delivered Medicare annual wellness visits. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

Pharmacy & health disparities: social determinants of health and their intersectionality with medication use, health outcomes, and clinical quality measures. Keynote address. Presented at: National Alliance of State Pharmacy Associations 2022 Fall Meeting; October 2022; Kansas City, MO.

What’s SDOH got to do with it? Heart failure management through a social determinants of health lens. Presented at: NPhA|SNPhA Annual Convention; July 2022; Atlanta, GA.

Pushing more than just pills: pharmacists promoting health equity. Keynote address. Presented at: 2022 Virginia Pharmacists Association Annual Convention; August 2022; Virginia Beach, VA.

 

New ACCP Fellows

• Faria Chaudhry

 

Other Notable Achievements

• Sally Arif:

Accepted as a member of the National Aeronautics and Space Administration (NASA) database of DEI practitioners who will evaluate the inclusion plans of submitted scientific proposals to enhance equity in STEM.

Awarded a Certificate of Special Recognition for leadership, expertise, and dedication to make the Inclusion, Diversity, Equity, in Academics (IDEA) program a reality and success for the MWU academic community.

• Robert Lazarchik: SDOH Health Equity Consultant working with several MCOs on how to use SDOH in analytics, quality, and population health to decrease expense and improve member health statuses.
• Sharmon P. Osae: Accepted as part of inaugural cohort for 2022–2023 ACCP Professional Leadership Development Program.

 

 

 

Grants

• Gionfriddo MR, Covvey JR: Enhancing Experimental Rigor Through Education in Evidence Synthesis. National Institutes of Health, National Institute of Neurological Disorders and Stroke. UE5: RFA-NS-21-033. August 2022 to 2025. Co-Primary Investigators ($268,974).

 

Publications

• Adeoye-Olatunde OA. Advancing pharmacy technician roles in addressing social determinants of health. J Am Pharm Assoc 2023;63:3-4.
• Waghmare PH, Huang CY, Jaynes HA, Green WM, Snyder ME, Adeoye-Olatunde OA, et al. Disparities in Medicare beneficiaries’ receiving medication synchronization. J Am Pharm Assoc 2022 Oct 22. [Epub ahead of print]
• Covvey JR, Blakely ML, Singh R, et al. Pharmacist, prescriber, and drug policy expert opinions on gabapentinoid misuse. Res Social Adm Pharm 2023;19:599-609.
• Chun H, Covvey JR, Nemecek BD, et al. Initiation of oral antihypertensives in hospitalized patients with hypertensive urgency: a descriptive study. Am J Health Syst Pharm 2022 Dec 2. [Epub ahead of print]
• Hamner AN, Andrick B, Mathur A, Gionfriddo MR. Cancer patients’ experience with a pharmacist-led oral chemotherapy clinic: a qualitative descriptive study. J Am Coll Clin Pharm 2023;6:24-8.
• Hor SY, Dadich A, Gionfriddo MR, et al. Research as care: practice-based knowledge translation as transformative learning through video-reflexive ethnography. Health Sociol Rev 2023 Jan 16. [Epub ahead of print]
• Jones LK, Sturm AC, Gionfriddo MR. Translating guidelines into practice via implementation science: an update in lipidology. Curr Opin Lipidol 2022;33:336-41.
• Hwang AY, Cardel MI, Smith SM. Racial and ethnic differences in blood pressure before and after the 2016 United States general election. Am J Hum Biol 2022;34:e23785.
• Bradley CL, McMillin SM, Hwang AY, et al. Tirzepatide, the newest medication for type 2 diabetes: a review of the literature and implications for clinical practice. Ann Pharmacother 2022 Nov 11. [Epub ahead of print]
• Soefje SA, Carpenter C, Carlson K, et al. Clinical administration characteristics of subcutaneous and intravenous administration of daratumumab in patients with multiple myeloma at Mayo Clinic Infusion Centers. JCO Oncol Pract 2023 Feb 9. [Epub ahead of print]
• Aguiar-Ibanez R, Scherrer E, Grebennik D, Cook J, Bagga S, Sawhney B, Khandelwal A, Soefje SA. Time and productivity loss associated with immunotherapy infusion for the treatment of melanoma in the United States: a survey of health care professionals. BMC Health Serv Res 2023;23:136.
• Omdahl TK, Stenzel JL, Pike ML, Conlon PM, Barry TA, Brown TM, Cambern KL, Davis KM, Fjerstad KA, Graner KK, Kuhn AK, Larson AP, Orandi AB, Smith EL, Soefje SA, et al. Pediatric chemotherapy infusions in outpatient examination rooms: a novel patient care approach. J Pediatr Hematol Oncol Nurs 2023 Feb 12. [Epub ahead of print]

 

Presentations

• Omolola A. Adeoye-Olatunde:

Journey toward social impact through community-based health services. Invited speaker at: Lead Forward Luminary Event; February 2023; West Lafayette, IN.

The road less traveled: establishing a health equity research institute within a college of pharmacy program. Invited speaker at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

Healthcare Panel – Older adult safety and wellness during the pandemic. Invited panelist at: CICOA Aging Advantages Faith Summit; October 2022; Indianapolis, IN.

Health Equity Council – A community health worker workforce development update. Invited speaker at: Minority Health Partners Conference; September 2022; Indianapolis, IN.

Engaging community health workers (CHWs) in research to advance health equity. Invited speaker at: Regenstrief Center for Healthcare Engineering Summit; September 2022; West Lafayette, IN.

Barriers, facilitators, and recommendations for implementing health information exchange in community pharmacies. Poster presented at: Academy Health Annual Conference on the Science of Dissemination and Implementation; December 2022; Washington, DC.

What predicts older adults’ self-reported medication deprescribing behaviors? The intertwined roles of social determinants of health and health beliefs. Poster presented at: Purdue University College of Pharmacy Research Day; November 2022; West Lafayette, IN.

Meeting people where they are: a novel naloxone distribution program offered at food pantries and homeless shelters. Presented at: Harm Reduction Conference; October 2022; San Juan, Puerto Rico.

A developmental, formative evaluation to inform implementation of bidirectional health information exchange in community pharmacies. Poster presented at: Indiana Clinical and Translational Sciences Institute Annual Meeting; September 2022; Indianapolis, IN.

Development of a social determinants of health (SDOH)-centered adapted Pharmacists’ Patient Care Process (PPCP). Poster presented at: Regenstrief Center for Healthcare Engineering Summit; September 2022; West Lafayette, IN.

• Michael Gionfriddo: Creating conversations using shared decision making. Presented at: Pennsylvania Pharmacists Association Annual Conference; October 2022; Pocono Manor, PA.
• Andrew Hwang: What is the best blood pressure goal? Depends on who you ask. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Mia Lussier: Use of guideline-concordant diabetes medications in an elderly population: a mixed methods study. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Scott Soefje:

Hazardous drug safety compliance throughout the clinical pathway with closed system transfer devices. Presented at: Oncology Excellence Days; June 2022; Riyadh, Dammam, and Jeddah, Saudi Arabia.

White bagging: how do we fight back. Presented at: Minnesota Society of Health-System Pharmacists Midyear Clinical Meeting; September 2022; Brooklyn Center, MN.

Optimizing solid tumor management with PARP inhibition. Presented at: Academy of Managed Care Pharmacy Nexus Meeting; October 2022; National Harbor, MD.

Decreasing drug waste, reducing drug costs, improving efficiency through automated chemotherapy dose rounding. Presented at: ASHP Midyear Clinical Meeting; December 2022; Las Vegas, NV.

Using an IV chemotherapy robot within a comprehensive cancer center. Presented at: ASHP Midyear Clinical Meeting; December 2022; Las Vegas, NV.

• Shirley Wong:

Strategies for culturally effective care: diverse and tailored communication and patient education. Invited presentation at: ASHP Midyear Clinical Meeting 2022; December 2022; Las Vegas, NV.

Less is more: deprescribing medications in the elderly to improve quality of life. Invited presentation at: CSHP Seminar 2022; November 2022; Anaheim, CA.

 

 

 

Awards

• Justin Arnall: ACCP New Clinical Practitioner Award.
• Shawn Griffin: ACCP Hematology/Oncology PRN Emerging Member Award.
• Kirollos Hanna: ACCP Hematology/Oncology PRN Practice Advancement Award.
• Onyebuchi Ononogbu: ACCP Hematology/Oncology PRN Patient Advocate Award.

 

Publications

• Arnall JR, Maples KT, Harvey RD, Moore DC. Daratumumab for the treatment of multiple myeloma: a review of clinical applicability and operational considerations. Ann Pharmacother 2022;56:927-40.
• Arnall JR, Moore DC, Michael M, et al. Measuring the impact of a pharmacist-driven blood factor education program: a prospective, single-center observational study. Hosp Pharm 2022 Dec 1. [Epub ahead of print]
• Chojecki AL, Arnall J, Boselli D, et al. Outcomes and hospitalization patterns of patients with acute myelogenous leukemia treated with frontline CPX-351 or HMA/venetoclax. Leuk Res 2022;119:106904.
• Ciolek AM, Arnall JR, Moore DC, et al. Eptacog beta for bleeding treatment and prevention in congenital hemophilia A and B with inhibitors: a review of clinical data and implications for clinical practice. Ann Pharmacother 2022;56:831-8.
• DiSogra K, Arnall J. Positive Quality Intervention: Proactive Symptom Management in Myelofibrosis. NCODA 2023 Feb 10.
• Tran TB, Downing L, Elmes JB, Arnall JR, Moore DC. Avatrombopag for the treatment of immune thrombocytopenia and periprocedural thrombocytopenia associated with chronic liver disease. J Pharm Pract 2022 Sep 15. [Epub ahead of print]

• Aycock AC, Smith JM, Coe KE, et al. 599: Association between vancomycin AUC and clinical failure in patients with streptococcal bacteremia. Open Forum Infect Dis 2022;9(suppl 2):ofac492.651.
• Dixon DL, Harris IM, Aljadeed R, Anderson K, Aycock A, et al. Overview of clinical practice guideline development, application to pharmacy practice, and roles for pharmacists. J Am Coll Clin Pharm 2023;6:73‐84.

• Barreto JN, Barreto EF, Mara KC, et al. Performance of glomerular filtration rate estimating equations in cancer patients evaluated for chimeric antigen receptor T-cell therapy. Blood 2022;140(suppl 1):10942-4.
• Barreto JN, Kashani KB, Mara KC, et al. A prospective evaluation of novel renal biomarkers in patients with lymphoma receiving high-dose methotrexate. Kidney Int Rep 2022;7:1690-3.
• Ibarra M, Combs R, Taylor ZL, Ramsey LB, Mikkelsen T, Buddington RK, Heldrup J, Barreto JN, et al. Insights from a pharmacometric analysis of HDMTX in adults with cancer: clinically relevant covariates for application in precision dosing. Br J Clin Pharmacol 2023;89:660-71.
• Powell MZ, Mara KC, Bansal R, Hathcock MA, Khurana A, Bennani NN, Wang Y, Paludo J, Bisneto JV, Ansell SM, Johnston PB, Lin Y, Barreto JN. Procalcitonin as a biomarker for predicting bacterial infection in chimeric antigen receptor T‐cell therapy recipients. Cancer Med 2023 Feb 8. [Epub ahead of print]

• Mangaonkar AA, Langer KJ, Lasho TL, Finke C, Litzow MR, Hogan WJ, Shah MV, Go RS, Bartoo G, et al. Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: data from a prospective series of patients. Am J Hematol 2023;98:E28-31.
• Halabi S, Zhou J, He Y, Bressler LR, et al. Landscape of coronavirus disease 2019 clinical trials: new frontiers and challenges. Clin Trials 2022;19:561-72.
• Bubalo JS, Radke JL, Bensch KG, et al. A phase II trial of netupitant/palonosetron for prevention of chemotherapy induced nausea/vomiting in patients receiving BEAM prior to hematopoietic cell transplantation [preprint]. Research Square 2022 Nov 3.
• Cohen J, Lee C, Markham R, Szerwo J, Roska M, Bubalo J. Medication use process and assessment of extemporaneous compounding and alternative routes of administration of oral oncology drugs: guidance for clinical and oncology pharmacists. J Am Coll Clin Pharm 2022;5:1176-228.
• Gu TM, Lewis JS, Le H, Bubalo JS. Comparative effects of fluconazole, posaconazole, and isavuconazole upon tacrolimus and cyclosporine serum concentrations. J Oncol Pharm Pract 2022;28:1357-62.
• McCollam S, Lewis JS, Bubalo J, et al. Pneumocystis jirovecii pneumonia prophylaxis with intravenous pentamidine in adult allogeneic hematopoietic stem cell transplant patients. Antimicrob Agents Chemother 2022;66:e00833-22.
• Ostrosky-Zeichner L, Nguyen MH, Bubalo J, et al. Multicenter registry of patients receiving systemic mold-active triazoles for the management of invasive fungal infections. Infect Dis Ther 2022;11:1609-29.

• Qualls D, Buege MJ, Dao P, et al. Tafasitamab and lenalidomide in relapsed/refractory large B cell lymphoma (R/R LBCL): real world outcomes in a multicenter retrospective study. Blood 2022;140(suppl 1):787-9.
• Sawalha Y, Goyal S, Switchenko JM, Romancik JT, Kamdar M, Greenwell IB, Hess BT, Isaac KM, Portell CA, Mejia Garcia AV, Goldsmith SR, Grover NS, Riedell PA, Karmali R, Burkart M, Buege M, et al. A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma. Blood Adv 2023 Feb 21. [Epub ahead of print]

• Chazan G, Jupp J, Bauters T, Duncan N, Weddle KJ, Nomura H, O’Connor S, Chan A, Alkhudair N, Alshamrani M, Buie LW. Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: an international survey of oncology pharmacy practitioners. J Oncol Pharm Pract 2022;28:1832-47.
• Finnes HD, Kennedy L, Buie LW, et al. Hematology‐oncology pharmacists: we hear you, we see you, we support you. J Am Coll Clin Pharm 2022;5:1325-6.
• McBride A, Hudson-DiSalle S, Pilz J, Hamm M, Boring B, Buie LW, et al. National survey on the effect of oncology drug shortages in clinical practice: a hematology oncology pharmacy association survey. JCO Oncol Pract 2022;18:e1289-96.

• Buatois EM, Akunna AA, Bailey T, Coomer TN, et al. Using the HyFlex model to deliver a capstone seminar course. Curr Pharm Teach Learn 2022;14:1109-15.
• Nix DE, Davis LE, Matthias KR. The relationship of vancomycin 24-hour AUC and trough concentration. Am J Health Syst Pharm 2022;79:534-9.
• Denson A, Croom Taylor M, Arnall J. Considerations for the role of the pharmacist in managing patients on eculizumab for hematopoietic stem cell transplantation–related thrombotic microangiopathy. Ann Pharmacother 2022 Sep 5. [Epub ahead of print]
• Cole KD, Adcock KG, Earl SR, et al. Virtual interprofessional team care planning and communication for chronic pain management: an educational model. J Interprof Educ Pract 2022;29:100552.
• Kolli A, Pina Y, Peguero E, Gatewood T, et al. Plasma exchange for immune checkpoint inhibitor induced acute demyelinating polyneuropathy refractory to IVIG. Neuro-Oncology 2022;24:194.
• Kundalia R, Hanini A, Gatewood T, et al. Managing central nervous system manifestations of chronic graft versus host disease following hematopoietic stem cell transplantation: a case report. Neuro-Oncology 2022;24:146.
• Piña Y, Aaroe A, Forsyth P, Gatewood TS, et al. Intrathecal treatments for leptomeningeal metastases. In: Tubbs RS, Iwanaga J, Rizk EB, et al., eds. Cerebrospinal Fluid and Subarachnoid Space. Academic Press, 2023:331-61.

• Abernathy KM, Perciavalle MA, Gatwood KS, et al. Real-world analysis of tumor lysis syndrome in patients started on venetoclax combination for acute myeloid leukemia. J Oncol Pharm Pract 2022 Aug 9. [Epub ahead of print]
• Farris KB, Cadwallader T, Farley J, Gatwood K, et al. Implementation of a model integrating primary and oncology pharmacists’ care for patients taking oral anticancer agents (OAA). Explor Res Clin Soc Pharm 2022;7:100163.
• Gatwood J, Dashputre A, Rajpurohit A, Gatwood K, et al. Medication adherence among adults with comorbid chronic conditions initiating oral anticancer agent therapy for multiple myeloma. JCO Oncol Pract 2022;18:e1475-83.
• Murphy D, Wilkerson K, Logue M, Vaughn LA, Akhom P, Biltibo E, Gatwood KS, et al. ABO incompatibility did not impact outcomes after haploidentical bone marrow transplantation with posttransplant cyclophosphamide for patients with sickle cell disease: single center experience. Transplant Cell Ther 2023;29:S298.
• Patel A, Wilkerson K, Chen H, Sharma D, Byrne M, Green J, Sengsayadeth S, Dholaria B, Savani B, Chinratanalab W, Jayani R, Gatwood K, et al. Reduction in the prevalence of thrombotic events in sickle cell disease after allogeneic hematopoietic transplantation. Transplant Cell Ther 2022;28:277-e1.
• Sowell H, Gatwood K, Perciavalle M. Incidence and severity of ICANS following CAR-T therapy in patients previously receiving ifosfamide. Bone Marrow Transplant 2023;58:219-21.
• Yuda S, Fuji S, Savani B, Gatwood KS. Antiemetic strategies in patients who undergo hematopoietic stem cell transplantation. Clin Hematol Int 2022;4:89-98.

• Yang A, Brown A, Gilmore R, et al. A practical review for implementing peer assessments within teams. Am J Pharm Educ 2022;86:8795.
• Ho TT, Bell G, Gammal RS, Gregornik D, et al. A clinician’s guide for counseling patients on results of a multigene pharmacogenomic panel. Am J Health Syst Pharm 2022;79:1634-44.
• Paetznick C, Gregornik D, Miller L, et al. Implementation of a clinical pharmacogenomics service in a large freestanding pediatric health system. Adv Mol Pathol 2022;5:119-29.
• Zhang L, Jacobson PA, Johnson AN, Gregornik DB, et al. Public attitudes toward pharmacogenomic testing and establishing a statewide pharmacogenomics database in the state of Minnesota. J Pers Med 2022;12:1615.

• Lee BJ, Griffin SP, Doh J, et al. CD19‐directed immunotherapy use in KMT2A‐rearranged acute leukemia: a case report and literature review of increased lymphoid to myeloid lineage switch. Am J Hematol 2022;97:E439-43.
• Lee BJ, Griffin SP, Doh J, et al. Timing of intrathecal chemotherapy and blinatumomab impacts neurotoxicity in acute lymphoblastic leukemia. Am J Hematol 2023 Feb 16. [Epub ahead of print]

• Andersson BS, Thall PF, Ma J, Valdez BC, Bassett R Jr, Chen J, Ahmed S, Alousi A, Bashir Q, Ciurea S, Gulbis A. A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan±clofarabine in allogeneic stem cell transplantation. Bone Marrow Transplant 2022;57:1295-303.
• Ngo-Huang A, Ombres R, Saliba RM, Szewczyk N, Adekoya L, Soones TN, Ferguson J, Fontillas RC, Gulbis AM, et al. Enhanced recovery stem-cell transplantation: multidisciplinary efforts to improve outcomes in older adults undergoing hematopoietic stem-cell transplant. JCO Oncol Pract 2023;19:e417-e427.
• Rao KV, Gulbis AM, Mahmoudjafari Z. Assessment of attrition and retention factors in the oncology pharmacy workforce: results of the oncology pharmacy workforce survey. J Am Coll Clin Pharm 2022;5:1112-20.
• Rao KV, Gulbis AM, Mahmoudjafari Z. Response to letters to the editor: “Assessment of attrition and retention factors in the oncology pharmacy workforce: results of the oncology pharmacy workforce survey.” J Am Coll Clin Pharm 2022;5:1327.

• Haidar CE, Crews KR, Hoffman JM, Relling MV, Caudle KE. Advancing pharmacogenomics from single-gene to preemptive testing. Ann Rev Genomics Hum Genet 2022;23:449-73.
• Gammal RS, Pirmohamed M, Somogyi AA, Morris SA, Formea CM, Elchynski AL, Oshikoya KA, McLeod HL, Haidar CE, et al. Expanded Clinical Pharmacogenetics Implementation Consortium guideline for medication use in the context of G6PD genotype. Clin Pharmacol Ther 2022 Sep 1. [Epub ahead of print]
• Marrs JC, Haidar CE. ASHP statement on pharmacist prescribing of statins. Am J Health Syst Pharm 2022;79:2182-4.
• Nguyen JQ, Crews KR, Moore BT, Kornegay NM, Baker DK, Hasan M, Campbell PK, Dean SM, Relling MV, Hoffman JM, Haidar CE. Clinician adherence to pharmacogenomics prescribing recommendations in clinical decision support alerts. J Am Med Inform Assoc 2023;30:132-8.

• Avinger AM, Sibold HC, Campbell G, Abernethy E, Bourgeois J, McClary T, Blee S, Dixon M, Harvey RD, et al. Improving oncology first-in-human and Window of opportunity informed consent forms through participant feedback. BMC Med Ethics 2023;24:12.
• Jimenez RB, Schenkel C, Levit LA, Hu B, Lei XJ, Harvey RD, et al. Oncologists’ perspectives on individualizing dose selection for patients with metastatic cancer. JCO Oncol Pract 2022;18:e1807-17.
• Papautsky EL, Carlson M, Johnson SM, Montague H, Valero L, Attai DJ, Harvey RD, et al. Webinar as an informational resource on trastuzumab biosimilars: planning, promotion, execution, and evaluation. Cancer Investig 2022;40:654-62.
• Schmeusser BN, Palacios AR, Midenberg ER, Nabavizadeh R, Patil DH, Harvey RD, et al. Race‐free renal function estimation equations and potential impact on Black patients: implications for cancer clinical trial enrollment. Cancer 2023;129:920-4.
• Williams GR, Outlaw D, Harvey RD, Lichtman SM, Zamboni WC, Giri S. Chemotherapy dosing in older adults with cancer: one size does NOT fit all. J Geriatr Oncol 2023;14:101363.
• Zhou X, Vaishampayan U, Mahalingam D, Harvey RD, et al. Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors. Invest New Drugs 2022;40:1042-50.

• Hayes S. Chronic myeloid leukemia. Adult hematologic malignancies. Koda-Kimble and Young’s Applied Therapeutics: The Clinical Use of Drugs, 12th ed. Lippincott Williams & Wilkins, 2023.
• Snyder BM, Lion AH, Helvie AE, et al. Targeted treatment of refractory primitive neuroectodermal tumor arising from an immature teratoma with crizotinib leading to a sustained response. Clin Case Rep 2023;11:e6779.

• Baker SD, Bates SE, Brooks GA, Dahut WL, Diasio RB, El-Deiry WS, Evans WE, Figg WD, Hertz DL, Hicks JK, Kamath S, Kasi PM, Knepper TC, McLeod HL, O’Donnell PH, Relling MV, Rudek MA, Sissung TM, Smith DM, Sparreboom A, Swain SM, Walko CM. DPYD testing: time to put patient safety first. J Clin Oncol 2023 Feb 23. [Epub ahead of print]
• Higgins T, Menditto MA, Katartzis S, et al. Advances in the management of sickle cell disease: new concepts and future horizons. J Pediatr Pharmacol Ther 2022;27:206-13.
• Doyno CR, Holle LM, Puente R, et al. Expansion of MyDispense: a descriptive report of simulation activities and assessment in a certified pharmacy technician training program. Pharmacy 2023;11:38.
• Hadfield MJ, Lyall V, Holle LM, et al. Updates in the treatment of non-metastatic castrate-resistant prostate cancer: the benefit of second-generation androgen receptor antagonists. Ann Pharmacother 2023 Feb 24. [Epub ahead of print]
• Loschiavo S, Elwell J, Holle L, et al. Designing, implementing, and evaluating an interprofessional survivorship model of care in an academic cancer center. J Oncol Navig Surviv 2022;13:12.
• Moran A, Elwell J, Holle L, et al. Development, implementation, and evaluation of an oral anticancer management program. J Nurse Pract 2022 Dec 12. [Epub ahead of print]

• Nasta SD, Hughes ME, Namoglu EC, et al. Outcomes of tisagenlecleucel in lymphoma patients with predominant management in an ambulatory setting. Clin Lymphoma Myeloma Leuk 2022;22:e730-7.

• Allen JD, Zhang L, Johnson AN, Jacobson PA, et al. Development and validation of the Minnesota Assessment of Pharmacogenomic Literacy (MAPL). J Pers Med 2022;12:1398.
• Brown JT, McGonagle E, Seifert R, Speedie M, Jacobson PA. Addressing disparities in pharmacogenomics through rural and underserved workforce education. Front Genet 2022;13:1082985.
• Butler T, Brown J, Jacobson PA, et al. Perceptions of pharmacogenetic exceptionalism and the implications for clinical management within an electronic health record. Clin Transl Sci 2022;15:2265-74.
• Carroll DM, Murphy S, Meier E, Rhodes K, Dorr C, Braaten G, Jacobson PA, et al. Exploring potential for a personalized medicine approach to smoking cessation with an American Indian tribe. Nicotine Tob Res 2023;25:120-6.
• Jaber MM, Takahashi T, Kirstein MN, Al‐Kofahi M, Jacobson PA, et al. Influence of renal function on phosphoramide mustard exposure: a nonlinear mixed‐effects analysis. J Clin Pharmacol 2023;63:135-42.
• Khan MH, Onyeaghala GC, Rashidi A, Holtan SG, Khoruts A, Israni A, Jacobson PA, et al. Fecal β-glucuronidase activity differs between hematopoietic cell and kidney transplantation and a possible mechanism for disparate dose requirements. Gut Microbes 2022;14:2108279.
• Reininger KA, Onyeaghala G, Anderson‐Haag T, Schladt DS, Wu B, Guan W, Dorr CR, Remmel RP, Mannon R, Matas AJ, Oetting WS, Jacobson PA. Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers. Clin Transplant 2022 Dec 26. [Epub ahead of print]
• Takahashi T, Jaber MM, Al-Kofahi M, Weisdorf D, Brunstein C, Bachanova V, Brundage RC, Jacobson PA, et al. Comparison of dose adjustment strategies for obesity in high-dose cyclophosphamide among adult hematopoietic cell transplantation recipients: pharmacokinetic analysis. Transplant Cell Ther 2022;28:845-e1.
• Wen YF, Jacobson PA, Oetting WS, et al. Knowledge and attitudes of incoming pharmacy students toward pharmacogenomics and survey reliability. Pharmacogenomics 2022;23:873-85.
• Zhang L, Jacobson PA, Johnson AN, et al. Public attitudes toward pharmacogenomic testing and establishing a statewide pharmacogenomics database in the state of Minnesota. J Pers Med 2022;12:1615.

• Borghol A, Jamero D, Ahmed F, et al. Evaluation of outcomes in patients receiving modafinil to improve alertness after traumatic brain injury. Med Res Arch 2022;10(10).
• Navari R, Binder G, Molasiotis A, Herrstedt J, Roeland EJ, Ruddy KJ, LeBlanc TW, Kloth DD, et al. Duration of chemotherapy-induced nausea and vomiting (CINV) as a predictor of recurrent CINV in later cycles. Oncologist 2022 Dec 17.
• Kolesar J, Peh S, Thomas L, et al. Integration of liquid biopsy and pharmacogenomics for precision therapy of EGFR mutant and resistant lung cancers. Mol Cancer 2022;21:61.
• Bhosale SS, Mandal A, Hou C, McCorkle JR, Schweer D, Hill KS, Subramanian V, Kolesar JM, et al. Mithplatins: mithramycin SA‐Pt (II) complex conjugates for the treatment of platinum‐resistant ovarian cancers. ChemMedChem 2023;18:e202200368.
• Chen L, Burkard M, Wu J, Kolesar JM, Wang C. Estimating the distribution of ratio of paired event times in phase II oncology trials. Stat Med 2023;42:388-406.
• Hoskins EL, Samorodnitsky E, Wing MR, Reeser JW, Hopkins JF, Murugesan K, Kuang Z, Vella R, Stein L, Risch Z, Yu L, Adebola S, Parachuri A, Carpten J, Chahoud J, Edge S, Kolesar J, et al. Pan-cancer landscape of programmed death ligand-1 and programmed death ligand-2 structural variations. JCO Precis Oncol 2023;7:e2200300.
• Hutchcraft ML, Zhang S, Lin N, Gottschalk GL, Keck JW, Belcher EA, Sears C, Wang C, Liu K, Dietz LE, Pickarski JC, Wei S, Cardarelli R, DiPaola RS, Kolesar JM. Real-world evaluation of a population germline genetic screening initiative for family medicine patients. J Pers Med 2022;12:1297.
• Jeong JC, Hands I, Kolesar JM, et al. Local data commons: the sleeping beauty in the community of data commons. BMC Bioinformatics 2022;23:386.
• Miller RW, Hutchcraft ML, Weiss HL, Wu J, Wang C, Liu J, Jayswal R, Buchanan M, Anderson A, Allison DB, El Khouli RH, Patel RA, Villano JL, Arnold SM, Kolesar JM. Molecular tumor board–assisted care in an advanced cancer population: results of a phase II clinical trial. JCO Precis Oncol 2022;6:e2100524.
• Myint ZW, Kolesar JM, McCorkle JR, et al. Correlation between trough level of abiraterone and prostate-specific antigen (PSA) response in metastatic hormone-sensitive prostate cancer. Med Sci Monit 2022;28:e938091.
• Schweer D, Anand N, Anderson A, McCorkle JR, Neupane K, Nail AN, Harvey B, Hill KS, Ueland F, Richards C, Kolesar J. Human macrophage-engineered vesicles for utilization in ovarian cancer treatment. Front Oncol 2023;12:7391.
• Seong CS, Huang C, Boese AC, Hou Y, Koo J, Mouw JK, Rupji M, Joseph G, Johnston HR, Claussen H, Switchenko JM, Behera M, Churchman M, Kolesar JM, et al. Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesis [preprint]. bioRxiv 2023 Jan 27.
• Krauss ZJ, Abraham M, Coby J. Clinical pharmacy services enhanced by electronic health record (EHR) access: an innovation narrative. Pharmacy 2022;10:170.
• Hohmann LA, Krauss Z, Patel J, et al. Public perceptions of community pharmacy-based naloxone services: a national cross-sectional survey. Pharmacy 2022;10:171.
• Grinalds MS, Yoder C, Krauss Z, et al. Scoping review of rational polytherapy in patients with drug‐resistant epilepsy. Pharmacotherapy 2023;43:53-84.
• Lavery L, DiSogra K, Lea J, Trufan SJ, Symanowski JT, Roberts A, Moore DC, et al. Risk factors associated with palbociclib-induced neutropenia in patients with metastatic breast cancer. Support Care Cancer 2022;30:9803-9.
• McCall AL, Lieb DC, Gianchandani R, MacMaster H, et al. Management of individuals with diabetes at high risk for hypoglycemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2023;108:529-62.
• Gammal RS, Pirmohamed M, Somogyi AA, Morris SA, Formea CM, Elchynski AL, Oshikoya KA, McLeod HL, et al. Expanded Clinical Pharmacogenetics Implementation Consortium guideline for medication use in the context of G6PD genotype. Clin Pharmacol Ther 2022 Sep 1. [Epub ahead of print]
• Hu Q, Hu J, Chen C, Wang Y, Zhang Y, Wan J, Jing O, Yi H, Wang S, Huang W, Liu J, Zhang W, McLeod HL, et al. Propranolol suppresses bladder cancer by manipulating intracellular pH via NHE1. Trans Androl Urol 2022;11:1083-95.
• Li W, Wan J, Chen C, Zhou C, Liao P, Hu Q, Hu J, Wang Y, Zhang Y, Peng C, Huang Y, Huang W, Zhang W, McLeod HL, et al. Dissecting the role of cell signaling versus CD8⁺ T cell modulation in propranolol antitumor activity. J Mol Med (Berl) 2022;100:1299-306.
• Shahamatdar S, Saeed-Vafa D, Linsley D, Khalil F, Lovinger KL, Li L, McLeod HL, et al. Deceptive learning in histopathology [preprint]. bioRxiv 2022 Apr 22.
• Shen D, Luo J, Chen L, Ma W, Mao X, Zhang Y, Zheng J, Wang Y, Wan J, Wang S, Ouyang J, Yi H, Liu D, Huang W, Chang W, Liu Z, McLeod HL, et al. PARPi treatment enhances radiotherapy-induced ferroptosis and antitumor immune responses via the cGAS signaling pathway in colorectal cancer. Cancer Lett 2022;550:215919.
• Walton NA, Hafen B, Graceffo S, Sutherland N, Emmerson M, Palmquist R, Formea CM, Purcell M, Heale B, Brown MA, Danford CJ, McLeod HL. The development of an infrastructure to facilitate the use of whole genome sequencing for population health. J Pers Med 2022;12:1867.
• Wang Y, Xiao F, Zhao Y, Mao CX, Yu LL, Wang LY, Xiao Q, Liu R, Li X, McLeod HL, et al. A two-stage genome-wide association study to identify novel genetic loci associated with acute radiotherapy toxicity in nasopharyngeal carcinoma. Mol Cancer 2022;21:169.
• Jao ME, Indorf AL, Segal EM, Miske AF, Eaton KD, Marsolini TL, Ghuman SK. Impact of institutional interventions on the rate of paclitaxel hypersensitivity reactions [preprint]. Research Square 2022 Jun 22.

• Monestime S, Al Sagheer T, Tadros M. Asciminib (Scemblix): a third-line treatment option for chronic myeloid leukemia in chronic phase with or without T315I mutation. Am J Health Syst Pharm 2023;80:36-43.
• Moniz R, Hanna KS. Positive quality intervention: management of hyperphosphatemia with a low-phosphorous diet. NCODA; 2(3):4.
• Moore DC, Arnall JR. Sutimlimab: a complement C1s inhibitor for the management of cold agglutinin disease–associated hemolysis. Ann Pharmacother 2022 Dec 8. [Epub ahead of print]
• Moore DC, Eagers KA, Janes A, et al. Tafasitamab and lenalidomide for relapsed/refractory diffuse large B-cell lymphoma in a patient on chronic intermittent hemodialysis. J Oncol Pharm Pract 2023;29:239-41.
• Moore DC, Elmes JB, Arnall JR, et al. Acquired thrombotic thrombocytopenic purpura associated with immune checkpoint inhibitors: a real-world study of the FDA adverse event reporting system. Int Immunopharmacol 2022;110:109015.
• Moore DC, Elmes JB, Arnall JR, Strassels SA, Patel JN. Immune checkpoint inhibitor‐induced acquired haemophilia: a pharmacovigilance analysis of the FDA adverse event reporting system. Haemophilia 2022;28:e145-8.
• Moore DC, Peery MR, Tobon KA, Raheem F, Hwang GS, Alhennawi L, Hughes ME. New and emerging therapies for the treatment of relapsed/refractory diffuse large B-cell lymphoma. J Oncol Pharm Pract 2022;28:1848-58.
• Meek B, Desai N, Moore DC, Tran T, Knovich MA, Arnall J. Real-world experience and considerations on concomitant caplacizumab and anticoagulation in thrombotic thrombocytopenic purpura. Ann Hematol 2023;102:457-9.
• Parish PC, Moore DC, Arnall J, Howell TJ, Dick B, Cambareri R. Platelet recovery with ibrutinib therapy in patient with treatment-refractory immune thrombocytopenia. Ann Hematol 2023;102:237-8.

• Nedved A, Maddocks K, Nowakowski GS. Clinical treatment guidelines for tafasitamab plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma. Oncologist 2023;28:199-207.
• Bi X, Gergis U, Wagner JL, Carabasi M, Filicko-O’Hara J, O’Hara W, et al. Outcomes of two-step haploidentical allogeneic stem cell transplantation in elderly patients with hematologic malignancies. Bone Marrow Transplant 2022;57:1671-80.
• Grosso D, Leiby B, Wilde L, Carabasi M, Filicko-O’Hara J, O’Hara W, et al. A prospective, randomized trial examining the use of G-CSF versus no G-CSF in patients post-autologous transplantation. Transplant Cell Ther 2022;28:831-e1.

• Albuquerque AS, Okumura LM, Betin-de-Moraes NR, et al. Pediatric-related risk factors in acute and delayed chemotherapy-induced nausea and vomiting: multivariate analysis. Braz J Oncol 2022;18:e-20200292.
• Antonini M, Pinheiro DJPDC, Matos ABMTB, Ferraro O, Mattar A, Okumura LM, et al. Impact of the COVID-19 pandemic on the breast cancer early diagnosis program in Brazil. Prev Med Rep 2023;32:102157.
• Kapoor R, Standaert B, Pezalla EJ, Demarteau N, Sutton K, Tichy E, Bungey G, Arnetorp S, Bergenheim K, Darroch-Thompson D, Meeraus W, Okumura LM, et al. Identification of an optimal COVID-19 booster allocation strategy to minimize hospital bed-days with a fixed healthcare budget. Vaccines 2023;11:377.
• Schiefferdecker PM, Chen IB, Bher FB, Aciolli LK, Bodanese G, Okumura LM, et al. Effects of therapeutic plasma exchange on a cohort of patients with severe coronavirus infection: real world evidence from Brazil. Hematol Transfus Cell Ther 2023 Feb 9. [Epub ahead of print]

• Li Y, Liu L, Sun H, Li N, Huang S, Olinger A, et al. Complete remission of Hodgkin’s lymphoma in a pediatric patient with TTN gene mutation treated with brentuximab vedotin combined chemotherapy without anthracyclines: a case report. Front Oncol 2022;12:1006166.
• Rahimi S, Ononogbu O, Mohan A, et al. Identifying the predictors of adherence to oral endocrine therapy in racial/ethnic minority patients with low socioeconomic status [preprint]. Research Square 2022 Dec 22.
• Rahimi S, Ononogbu O, Mohan A, et al. Predictors of adherence to oral endocrine therapy in racial and ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemic. Cancer Res 2022;82(suppl).

• Huang TY, Rodriguez-Watson C, Wang T, Calhoun SR, Marshall J, Burk J, Nam YH, Mendelsohn AB, Jamal-Allial A, Greenlee RT, Selvan M, Pawloski PA, et al. Using the IMEDS distributed database for epidemiological studies in type 2 diabetes mellitus. BMJ Open Diabetes Res Care 2022;10:e002916.
• Margolis KL, Bergdall AR, Crain AL, JaKa MM, Anderson JP, Solberg LI, Sperl-Hillen J, Beran M, Green BB, Haugen P, Norton CK, Kodet AJ, Sharma R, Appana D, Trower N, Pawloski PA, et al. Comparing pharmacist-led telehealth care and clinic-based care for uncontrolled high blood pressure: the Hyperlink 3 Pragmatic Cluster-Randomized Trial. Hypertension 2022;79:2708-20.
• Margolis KL, Crain AL, Green BB, O’Connor PJ, Solberg LI, Beran M, Bergdall AR, Pawloski PA, et al. Comparison of explanatory and pragmatic design choices in a cluster-randomized hypertension trial: effects on enrollment, participant characteristics, and adherence. Trials 2022;23:673.
• Re VL, Dutcher SK, Connolly JG, Perez-Vilar S, Carbonari DM, DeFor TA, Djibo DA, Harrington LB, Hou L, Hennessy S, Hubbard RA, Kempner ME, Kuntz JL, McMahill-Walraven CN, Mosley J, Pawloski PA, et al. Association of COVID-19 vs influenza with risk of arterial and venous thrombotic events among hospitalized patients. JAMA 2022;328:637-51.
• Shinde M, Rodriguez-Watson C, Zhang TC, Carrell DS, Mendelsohn AB, Nam YH, Carruth A, Petronis KR, McMahill-Walraven CN, Jamal-Allial A, Nair V, Pawloski PA, et al. Patient characteristics, pain treatment patterns, and incidence of total joint replacement in a US population with osteoarthritis. BMC Musculoskelet Disord 2022;23:1-8.
• Anand N, Peh KH, Kolesar JM. Macrophage repolarization as a therapeutic strategy for osteosarcoma. Int J Mol Sci 2023;24:2858.

• Persson B, Fanning BR. Positive Quality Intervention: Fam-Trastuzumab Deruxtecan-nxki (Enhertu®) Management. NCODA.
• Shultz C, Gates C, Petros W, et al. Association of genetic variants and survival in patients with acute myeloid leukemia in rural Appalachia. Cancer Rep 2023;6:e1746.
• Raheem F, Ofori H, Simpson L, et al. Abemaciclib: the first FDA-approved CDK4/6 inhibitor for the adjuvant treatment of HR+ HER2− early breast cancer. Ann Pharmacother 2022;56:1258-66.
• Menezes MC, Raheem F, Mina L, et al. PARP inhibitors for breast cancer: germline BRCA1/2 and beyond. Cancers 2022;14:4332.
• Abdul-Mutakabbir JC, Tillman F III, Marcelin JR, Saunders IM, Arya V. Slowed progression: the utility of Test to Treat initiatives in improving the neglected inequities of COVID-19 among racially/ethnically minoritized groups. J Am Pharm Assoc 2023;63:424-9.
• Rath C, Yoo C, Cheplowitz H, Lo M, Young R, Guglielmo J, Saunders IM, et al. Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myeloma. J Oncol Pharm Pract 2023 Feb 2. [Epub ahead of print]
• Salama E, Lam S, Gonsalves WI, Tzachanis D, Momper JD, Saunders IM. Estimation of kidney function in patients with multiple myeloma: implications for lenalidomide dosing. Ann Pharmacother 2023;57:29-35.
• Sepassi A, Saunders IM, Bounthavong M, et al. Cost effectiveness of letermovir for cytomegalovirus prophylaxis compared with pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients in the United States. Pharmacoecon Open 2023 Feb 25. [Epub ahead of print]
• Krapfl A, McLeod C, Myers R, Venugopal P, Seddon A. Venetoclax ramp-up with concurrent voriconazole in a patient with chronic lymphocytic leukemia. J Oncol Pharm Pract 2022;28:1898-901.
• Jacobs G, Dizon D, Augustyniak M, Smith J, et al. Knowledge and skill gaps in the treatment and management of patients with endometrial cancer: a mixed-methods needs assessment in the US (577). Gynecol Oncol 2022;166(suppl 1):S280-1.
• Soefje S. Adoption of biosimilars – why the delay? J Hematol Oncol Pharm 2022;12:117-8.
• Soefje SA, Carpenter C, Carlson K, et al. Clinical administration characteristics of subcutaneous and intravenous administration of daratumumab in patients with multiple myeloma at Mayo Clinic Infusion Centers. JCO Oncol Pract 2023 Feb 9. [Epub ahead of print]
• Aguiar-Ibáñez R, Scherrer E, Grebennik D, Cook J, Bagga S, Sawhney B, Khandelwal A, Soefje SA. Time and productivity loss associated with immunotherapy infusions for the treatment of melanoma in the United States: a survey of health care professionals and patients. BMC Health Serv Res 2023;23:136.
• Booth JP, Kennerly-Shah JM, Kelley LR, Capozzi D, Prescott HA, Soefje SA, et al. Which hematology/oncology patients are high priority for ambulatory clinical pharmacist review? A three-round Delphi survey by the National Comprehensive Cancer Network. J Oncol Pharm Pract 2023 Feb 19. [Epub ahead of print]
• Golbach AP, McCullough KB, Soefje SA, et al. Evaluation of burnout in a national sample of hematology-oncology pharmacists. JCO Oncol Pract 2022;18:e1278-88.
• Omdahl TK, Stenzel JL, Pike ML, Conlon PM, Barry TA, Brown TM, Cambern KL, Davis KM, Fjerstad KA, Graner KK, Kuhn AK, Larso AP, Orandi AB, Smith EL, Soefje SA, et al. Pediatric chemotherapy infusions in outpatient examination rooms: a novel patient care approach. J Pediatr Hematol Oncol Nurs 2023 Feb 12. [Epub ahead of print]

• Golbach AP, Taraba JL, Smith MD, et al. Time to first palbociclib prescription dispense at Mayo Clinic: comparing a health-system specialty pharmacy with external specialty pharmacies. J Hematol Oncol Pharm 2022;12(5).
• Fadul J, Moore J, Treptow C, et al. Multiple myeloma therapy often causes cardiovascular complications. Pharmacy Times 2023;12:1.
• Lattuca FA, Moore J, Treptow C, et al. Bleeding and venous thromboembolism events in cancer patients taking direct oral anticoagulants vs. low molecular weight heparin. Thromb Update 2023;10:100129.
• Pillinger KE, Treptow CF, Dick TB, et al. Development and implementation of pharmacy department and pharmacy resident well-being programs. Am J Health Syst Pharm 2022;79:1337-44.

• Romancik JT, Chen Z, Allen PB, Waller EK, Valla K, et al. Ixazomib with or without rituximab following maintenance autologous stem cell transplant in mantle cell lymphoma: a single-center phase I trial. Clin Lymphoma Myeloma Leuk 2022;22:e1084-91.
• Viehl E, Lichvar A, Chan C, et al. Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center. Transpl Infect Dis 2022;24:e13867.
• Battisti NM, De Glas N, Soto-Perez-de-Celis E, Liposits G, Bringuier M, Walko C, et al. Chemotherapy and gene expression profiling in older early luminal breast cancer patients: an International Society of Geriatric Oncology systematic review. Eur J Cancer 2022;172:158-70.
• Gaber O, Karan C, Walko CM, et al. Effect of immunotherapy on the survival outcomes in tumor mutational burden-high (TMB-H) microsatellite stable (MSS) metastatic colorectal cancer (mCRC): a single-institution experience. J Clin Oncol 2023;41(no. 4 suppl):239.
• Karan C, Tan E, Sarfraz H, Knepper TC, Walko CM, et al. Human epidermal growth factor receptor 2–targeting approaches for colorectal cancer: clinical implications of novel treatments and future therapeutic avenues. JCO Oncol Pract 2022;18:545-54.
• King I, Saliba J, Danos A, Gonzalez A, Baumann B, Walko C, et al. 15. ClinGen Somatic Cancer expert curation panel for FGFR genes in Genitourinary Cancer. Cancer Genet 2022;268-269(suppl 1):5-6.
• Miao R, Bui MM, Walko C, et al. A malignant glomus tumor of the liver harboring MIR143-NOTCH2 rearrangement: from diagnosis to management. Cureus 2022;14:e30718.

• Riley TR, Douglas JS, Wang C, et al. An update of the pharmacological treatment options for generalized myasthenia gravis in adults with anti–acetylcholine receptor antibodies. Am J Health Syst Pharm 2023 Feb 13. [Epub ahead of print]
• Chazan G, Jupp J, Bauters T, Duncan N, Weddle KJ, et al. Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: an international survey of oncology pharmacy practitioners. J Oncol Pharm Pract 2022;28:1832-47.
• Leidy SB, Hull LR, Macik MR, Gonzalvo JD, Weddle KJ. Retrospective assessment of chemotherapy/biotherapy toxicity in a Hispanic/Latinx population versus published study population. J Oncol Pharm Pract 2023;29:66-73.
• Lin ID, Shotts MB, Al-Hader A, Weddle KJ, et al. Examining adherence to oral anticancer medications through a human factors engineering framework: protocol for a scoping review. PLoS One 2022;17:e0274963.

• Anghelescu DL, Ryan S, Wu D, et al. Low‐dose ketamine infusions reduce opioid use in pediatric and young adult oncology patients. Pediatr Blood Cancer 2022;69:e29693.
• Lindsay J, Krantz EM, Morris J, Sweet A, Tverdek F, Joshi A, Yeh R, et al. Voriconazole in hematopoietic stem cell transplantation and cellular therapies: real-world usage and therapeutic level attainment at a major transplantation center. Transplant Cell Ther 2022;28:511-e1.
• Martin J, Zacholski E, Matulonis U, et al. Society of Gynecologic Oncology Journal Club: Controversial conversations in gynecologic cancer – the ABCs of ADCs (antibody drug conjugates). Gynecol Oncol Rep 2023;45:101141.
• Zacholski K, Hambley B, Hickey E, et al. Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia. J Oncol Pharm Pract 2022;28:1340-9.
• Bouligny IM, Murray G, Tran V, Gor J, Hang Y, Alnimer Y, Zacholski K, et al. Real-world safety and efficacy of gemtuzumab ozogamicin in relapsed or refractory AML. Blood 2022;140(suppl 1):11744.

 

New ACCP Fellows

• Donald C. Moore III

 

 

 

Promotions

• Crystal Hodge: Assistant to Associate Professor, University of North Texas Health Science Center.
• Stephanie Kirk: Clinical Associate Professor, Division of Infectious Diseases, Medical University of South Carolina College of Medicine.

 

Awards

• Stephanie Kirk: ID Teacher of the Year in August 2022, Medical University of South Carolina College of Medicine.

 

Publications

• Brizzi MB, Perez SE, Michienzi SM, Badowski ME. Long-acting injectable antiretroviral therapy: will it change the future of HIV treatment? Ther Adv Infect Dis 2023;10:20499361221149773.
• Buscemi L, Mossholder B. Achievement of virologic suppression with HIV antiretroviral therapy in a patient also taking multiple daily cation supplement doses: a case report and review of the literature. Am J Health Syst Pharm 2023;80:196-9.
• Harris TN, Buscemi LR. Evaluation of treatment simplification strategies in patients living with HIV with multi-drug resistance. Ther Adv Infect Dis 2023;10:20499361221149869.
• Chastain DB, Kung VM, Vargas Barahona L, et al. Characteristics and outcomes of cryptococcosis among patients with and without COVID-19. J Fungi (Basel) 2022;8:1234.
• Chastain DB, Motoa G, Ortiz-Martínez Y, et al. Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: a retrospective cohort. AIDS 2023;37:611-6.
• Osae SP, Chastain DB, Young HN. Access to media and emerging technologies: an evolving opportunity for pharmacists to contribute to improving health outcomes. J Pharm Pract 2023 Jan 5. [Epub ahead of print]
• Marx AH, Cluck D, Green SB, Anderson DT, Stover KR, Chastain DB, et al. A baker’s dozen of top antimicrobial stewardship intervention publications for hospitalized patients in 2021. Open Forum Infect Dis 2022;9:ofac600.
• Latham AH, Nissim OA, Spitznagel MC, Kirk SE, et al. Impact of integrase strand transfer inhibitor use during pregnancy on viral suppression at delivery and infant outcomes: a statewide retrospective cohort study. J Acquir Immune Defic Syndr 2022;89:448-53.
• Lantz A, Nicol MR. Translational models to predict target concentrations for PrEP in women. AIDS Res Hum Retrovirus 2022;38:909-23.
• Wang F, Namuju OC, Pastick KA, Abdusalaamu K, Mishra U, Collins L, Boulware DR, Lukande R, Meya DB, Nicol MR. A post-mortem analysis of tenofovir, lamivudine, and fluconazole concentrations in female genital tissues. J Antimicrob Chemother 2022;77:3180-6.

 

 

 

Promotions

• Stephanie Yasechko: Pharmacy Clinical Specialist in Pediatric Lung Transplantation, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH.

 

Publications

• Benken J, Lichvar A, Benedetti E, et al. Perioperative vasopressors are associated with delayed graft function in kidney transplant recipients in a primarily Black and Hispanic cohort. Prog Transplant 2022;32:167-73.
• Andrews L, Benken J, Benedetti E, et al. Effects of angiotensin II in the management of perioperative hypotension in kidney transplant recipients. Clin Transplant 2022;36:e14754.
• Koh W, Rao SB, Yasechko SM, et al. Postoperative management of children after lung transplantation. Semin Pediatr Surg 2022;31:151179.

 

Presentations

• Jamie Benken: Less is more: optimizing opioid use in organ transplant as part of session updates in solid organ transplantation: a focus on new and hot topics in abdominal and cardiothoracic transplant and transplant infectious diseases. Presented at: ASHP Midyear Clinical Meeting 2022; December 2022; Las Vegas, NV.
• Eve Carciofi: Effect of antiproliferative dose on clinical outcomes in adult kidney transplant patients maintained on belatacept. Presented at: ASHP Midyear Clinical Meeting; December 2022; Las Vegas, NV.

 

 

 

Promotions

• Rachel Britt: PGY1 Residency Program Coordinator, UTMB Health, Galveston, TX.
• Crystal Hodge: Associate Professor of Pharmacotherapy, University of North Texas Health Science Center at Fort Worth College of Pharmacy, Fort Worth, TX.

 

Awards

• Wes Kufel: 2022 Clinical Practitioner of the Year Award, New York State American College of Clinical Pharmacy.

 

Publications

• Gens KD, Singer RS, Dilworth TJ, Heil EJ, et al. Antimicrobials in animal agriculture in the United States: a multidisciplinary overview of regulation and utilization to foster collaboration: on behalf of the Society of Infectious Diseases Pharmacists. Open Forum Infect Dis 2022;9:ofac542.
• El Nekidy WS, Mallat J, Nusair AR, et al. Urinary tract infections in hemodialysis patients – the controversy of antimicrobial drug urine concentrations. Hemodial Int 2022;26:548-54.
• Hashmani S, Madhyastha R, El Nekidy W, et al. Polypharmacy in cardiorenal syndrome patients. Clin Nephrol 2023;99:141-8.
• Field AM, Seabury RW, Kufel WD, et al. Single-dose antibiotic prophylaxis with ertapenem increases compliance with recommendations for surgical antibiotic prophylaxis in elective colorectal surgery: a retrospective, single-center analysis. Surg Infect (Larchmt) 2023;24:177-82.
• Gauthier TP, Menendez Alvarado LR, Collongette EM, et al. The infectious diseases pharmacist: an essential partner for health-system leadership in keeping pace with the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol 2023;44:520-1.
• Bollig ER, Hirsch EB, Bueno I, Lynfield R, Granick JL, Gens KD, Rashid A, Harris K, Boeser K, et al. Minnesota One Health Antibiotic Stewardship Collaborative: a reproducible approach to facilitate antimicrobial stewardship progress. Open Forum Infect Dis 2022;9:ofac602.
• Palasik-Torres B, Hodge CK, Benavides TM, et al. Innovative approach to career pathway mentorship for pharmacy post-graduate training. Pharm Educ 2023;23:127-31.
• Larry RC, Hoff BM, Bertram CM. Evaluation of microbiological concordance of a rapid molecular diagnostic pneumonia panel in a real-world population with pneumonia. J Appl Lab Med 2023 Jan 31. [Epub ahead of print]
• Kufel WD, Parsels KA, Blaine BE, et al. Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia. Pharmacotherapy 2023;43:15-23.
• Belz SN, Seabury RW, Steele JM, Darko W, Miller CD, Probst LA, Kufel WD. Accuracy of 4 free online dosing calculators in predicting the vancomycin area under the concentration-time curve calculated using a 2-point pharmacokinetic approach. Ann Pharmacother 2023;57:432-40.
• Hitchcock AM, Seabury RW, Kufel WD, et al. Does a positive methicillin-resistant Staphylococcus aureus (MRSA) nasal screen predict the risk for MRSA skin and soft tissue infection? Ann Pharmacother 2022 Oct 12. [Epub ahead of print]
• Lessard S, Huiras C, Dababneh A, et al. Pharmacist adjustment of preoperative antibiotic orders to the preferred preoperative antibiotic cefazolin for patients with penicillin allergy labeling. Am J Health Syst Pharm 2022 Dec 25. [Epub ahead of print]
• Lessard S, Zimmermann E, Patel L, Fung B, Rivera CG. Putting words into action: adopting vancomycin infusion reaction terminology. Am J Health Syst Pharm 2023;80:175-6.
• Nelson JM, Woolever N, Meyer L, Hall S, Stakston J, Dababneh A, Roush K, Van Sistine M, Tempelis J, Dierkhising RA, Lessard S. ROAR ED-SANE: a retrospective observational assessment review of an emergency department sexual assault nurse examiner program’s adherence to Centers for Disease Control and Prevention guidelines for sexually transmitted infections. Sex Transm Dis 2023;50:167-71.
• Wu E, Osborn RL, Bertram CM, Moore WJ, et al. Tecovirimat use in ambulatory and hospitalized patients with monkeypox virus infection. Sex Transm Dis 2023;50:172-4.
• An G, Creech CB, Wu N, Nation RL, Gu K, Nalbant D, Jimenez-Truque N, Fissell W, Rolsma S, Patel PC, et al. Evaluation of empirical dosing regimens for meropenem in intensive care unit patients using population pharmacokinetic modeling and target attainment analysis. Antimicrob Agents Chemother 2023;67:e0131222.
• Slain D, Howard C, Cooper CG. An antimicrobial treatment assessment of Serratia marcescens bacteremia and endocarditis. Front Antibiot 2022;1:942721.
• Al-Mamun MA, Strock J, Sharker Y, Shawwa K, Schmidt R, Slain D, et al. Evaluating the medication regimen complexity score as a predictor of clinical outcomes in the critically ill. J Clin Med 2022;11:4705.
• Spigelmyer A, Howard C, Rybakov I, Burwell S, Slain D. Impact of clinical pharmacist discharge prescription review on the appropriateness of antibiotic therapy: a retrospective comparison. Int J Clin Pharm 2022 Nov 23. [Epub ahead of print]
• Alowais SA, Wali HA, Tabb D, et al. Assessing tobramycin levels and renal function following the implantation of CaSO4 beads impregnated with tobramycin: a prospective cohort study. Medicine 2022;101:e32276.
• Welch R, Hayes T, Mitchell K, Ford W. A case of Campylobacter bacteremia. J Mississippi State Med Assoc 2022;63(11/12).

 

Presentations

• Rachel Britt: Extending stewardship through tele-stewardship/outpatient parenteral antibiotic therapy (OPAT) initiatives. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Olga DeTorres: A case on medical tourism. Presented at: Infectious Disease Association of California 37th Annual Fall Symposium; November 2022; Long Beach, CA.

 

Other Notable Achievements

• Allison Field: AAHIVP
• Timothy Gauthier: Published his first book, Learn Antibiotics.
• Salam Kabbani: Published a memoir, COVID Long-Hauler: My Life Since COVID.
• Olivia Knack: BCIDP
• Wes Kufel: BCIDP Specialty Council Member, Board of Pharmacy Specialties.
• Caleb Rux: BCIDP
• Haytham Wali: BCIDP
• Ron Welch: BCIDP

 

 

 

Grants

• Linda Awdishu: Amendment 3 to grant Development of Artificial Intelligence Model to Evaluate Human Communication in Simulation Activities. Sony Electronics ($26,753).

 

Publications

• Yousif Z, Awdishu L. Drug-induced acute kidney injury risk prediction models. Nephron 2023;147:44-7.
• El Nekidy WS, Mallat J, Nusair AR, et al. Urinary tract infections in hemodialysis patients – the controversy of antimicrobial drug urine concentrations. Hemodial Int 2022;26:548-54.
• Hashmani S, Madhyastha R, El Nekidy W, et al. Polypharmacy in cardiorenal syndrome patients. Clin Nephrol 2023;99:141-8.
• Flurie RW. Disorders of potassium and magnesium homeostasis. In: DiPiro JT, Yee GC, Haines ST, et al., eds. Pharmacotherapy: A Pathophysiologic Approach, 12th ed. McGraw-Hill, 2022.
• Flurie RW, Hylton Gravatt LA, Radwan RM, et al. Residents’ assessment of mentoring received on lecture performance in a teaching and learning curriculum program. Curr Pharm Teach Learn 2022;14:1463-70.
• Flurie R, Szwark JA, Beck T, Herink MC, Wdowiarz K, Hong L, Hellwig T, Nemecek BD, et al. Internal medicine pharmacy residency programs: residents’ pursuit of post-residency positions and job market perceptions. J Am Coll Clin Pharm 2023;6:103-10.
• Gibson CM, Flurie RW. Nonsteroidal MRAs: will finerenone take the throne? Cardiology Today. November 2022.
• Fravel MA, Ernst ME. Gout and hyperuricemia. In: DiPiro JT, Yee GC, Haines ST, et al., eds. Pharmacotherapy: A Pathophysiologic Approach, 12th ed. McGraw-Hill, 2022.
• Fravel MA, Ernst ME, Webb KL, et al. GFR variability, survival and cardiovascular events in older adults. Kidney Med 2023;5:100583.
• Ernst ME, Fravel MA. Thiazide and the thiazide-like diuretics: review of hydrochlorothiazide, chlorthalidone, and indapamide. Am J Hypertens 2022;35:573-86.
• Saifuddin E, Woods R, Ryan J, Espinoza S, Gilmartin-Thomas J, Shah R, Mehta R, Kochar B, Lowthian J, Lockery J, Orchard S, Nelson M, Fravel M, et al. The association between polypharmacy, frailty and disability-free survival in community-dwelling healthy older individuals. Arch Gerontol Geriatr 2022;101:104694.
• Jang SM, Lewis SJ, Rhie SJ. Optimal antipseudomonal ꞵ-lactam drug dosing recommendations in critically ill Asian patients receiving CRRT. J Crit Care 2022;72:154172.
• Sember AM, LoFaso ME, Lewis SJ. Author response: “An optimal extended-infusion dosing of cefepime and ceftazidime in critically ill patients with continuous renal replacement therapy.” J Crit Care 2022;70:154059.
• Chun H, Covvey JC, Zimmerman DE, Nemecek BD. Initiation of oral antihypertensives in hospitalized patients with hypertensive urgency: a descriptive study. Am J Health Syst Pharm 2022 Dec 2. [Epub ahead of print]
• Nguyen T, Wang Z. Nonsteroidal anti-inflammatory drugs use in older adults and kidney disease [letter]. Am J Ther 2022 Sep 6. [Epub ahead of print]
• Nguyen T, Wang A. Beta-blocker use in cocaine users: is the contraindication real? (Special Continuing Education Edition). N J J Pharm 2022;XCVI:5-10.
• Nguyen T, Wang Z. Antithrombotic medications: risk versus benefits of dual and triple therapies. J Nurse Pract 2022;18:1024-6.
• Wong E, Cope R, Dima L, Nguyen T. Tirzepatide: a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 agonist for the management of type 2 diabetes mellitus. Am J Ther 2023;30:e26-e35.
• Kumar A, Lutsey PL, St. Peter WL, et al. Comparative effectiveness of ticagrelor, prasugrel, and clopidogrel for secondary prophylaxis in acute coronary syndrome: a propensity score-matched cohort study. Clin Pharmacol Ther 2023;113:401-11.
• Kumar A, Lutsey PL, St. Peter WL, et al. Comparative effectiveness of ticagrelor, prasugrel, and clopidogrel for secondary prophylaxis in acute coronary syndrome: a propensity score-matched cohort study. Clin Pharmacol Ther 2023;113:412-22.
• Richardson M, Grandinetti A, Hilliard-Boone TS, Wilund KR, Wingard R, St. Peter WL, et al. Conceptual framework for patient-reported outcome measures in clinical trials of skeletal muscle cramping experienced in dialysis: a Kidney Health Initiative Workgroup Report. Clin J Am Soc Nephrol 2022;17:1563-74.
• Zhao J, Weinhandl EW, Carlson AM, St. Peter WL. Disparities in SGLT2 inhibitor or glucagon-like peptide 1 receptor agonist initiation among Medicare insured adults with CKD in the United States. Kidney Med 2022;5:100564.

 

Presentations

• Awdishu L: Drug dosing in AKI including the impact of RRT. Speaker. Presented at: American Society of Nephrology 2022 Meeting; November 2022; Orlando, FL.
• Fravel MA: Chlorthalidone and kidney disease. iForumRx Podcast Series; March 20.
• Jang SM, Lewis SJ, Mueller BA: Levofloxacin dosing recommendations for home hemodialysis (HHD). Poster presented at: American Society of Nephrology Kidney Week 2022 Meeting; November 2022; Orlando, FL.
• Lewis SJ: Monte Carlo simulation to predict optimal ceftazidime/avibactam dosing regimens for critically ill patients receiving continuous renal replacement therapy. Poster presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Lewis SJ, Churchwell MD: Stability and compatibility of combined vancomycin and cefepime in two conventional peritoneal dialysis solutions. Poster presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Lewis SJ, Jang SM, Mueller BA:

Meropenem dosing recommendations in patients receiving home hemodialysis using Monte Carlo simulation. Poster presented at: 2022 ASHP Midyear Clinical Meeting; December 2022; Las Vegas, NV.

Determining vancomycin dosing recommendations in patients receiving home hemodialysis (HHD) using Monte Carlo simulations. Poster presented at: American Society of Nephrology Kidney Week 2022 Meeting; November 2022; Orlando, FL.

Ceftazidime dosing recommendations in patients receiving various home hemodialysis regimens. Poster presented at: American Society of Nephrology Kidney Week 2022 Meeting; November 2022; Orlando, FL.

Daptomycin dosing recommendations in patients receiving home hemodialysis using Monte Carlo simulation. Poster presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

• Nguyen T: What’s new in renal pharmacology? Presented at: Nephrology Nursing Symposium at Mount Sinai Kidney Center; October 2022; New York, NY.
• St. Peter WL:

The advancing American Kidney Health initiative – an opportunity to optimize medication management through interprofessional collaboration. Webinar presented at: Nephrology Grand Rounds, University of Tennessee Health Science Center, Division of Nephrology; August 2022; virtual.

Addressing medication-related disparities in persons with kidney disease – new non–race-based equations to assess kidney function and promote health equity. Webinar presented at: Many Faces of Community Health Conference, Minnesota; August 19, 2022; virtual.

Advancing kidney health through optimal medication management. Webinar presented at: American Association of Kidney Patients 47th Annual National Patient Meeting; September 2022; virtual.

Non–race-based eGFR equations – implications for medication-related decision-making. Webinar presented at: ASHP; September 2022; virtual.

Rebalancing the equation: (re) appropriating race-based modifiers in kidney disease. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

 

Other Notable Achievements

• Linda Awdishu: Grant Reviewer, FDA Office of the Chief Scientist Intramural Grants Program.
• Hanlin Li: Has partnered with two colleagues to create children’s books to foster critical thinking skills in children and bring awareness to the STEM fields.

 

New ACCP Fellows

• Michelle Fravel

 

 

 

Members of the Pediatrics PRN would like to honor two outstanding members of the College and the PRN who recently died: Kimberly Tallian (d. January 16, 2023) and Varsha Bhatt-Mehta (d. February 16, 2023). They leave an indelible mark on our PRN history and a notable influence and contribution to pediatric pharmacy practice that surpasses their time with us. They will be greatly missed.

 

Promotions

• Ingrid Pan: Clinical Assistant Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO.

 

Awards

• Gustavo Alvira-Arill: Pediatrics PRN Resident/Student Fellow Travel Award, American College of Clinical Pharmacy.
• Deborah S. Bondi: Pediatrics PRN Chair Award, American College of Clinical Pharmacy.
• Allison M. Chung: Pediatrics PRN Achievement Award, American College of Clinical Pharmacy.
• Emily Spencer: Center for Clinical Excellence Award, Nationwide Children’s Hospital.
• Autumn Spyhalsky: Pediatrics PRN Student Travel Award, American College of Clinical Pharmacy.
• Jeremy Stultz: Pediatrics PRN Outstanding Practitioner Award, American College of Clinical Pharmacy.

 

Grants

• Lucas Orth: Optimizing the Clinical Management of Polypharmacy for Children with Medical Complexity. Agency for Healthcare Research and Quality (R01). Co-Investigator ($2,055,594).

 

Publications

• Beckman EJ, Hovey S, Bondi D, et al. Pediatric perioperative clinical pharmacy practice: clinical considerations and management: an opinion of the Pediatrics and Perioperative Care Practice and Research Networks of the American College of Clinical Pharmacy. J Pediatr Pharmacol Ther 2022;27:490-505.
• Beckman EJ, Kiskaddon A. Congenital heart disease in adults. In: Jackevicius CA, Patterson JH, eds. Cardiology Self-Assessment Program, 2022 Book 2. Special Populations. American College of Clinical Pharmacy, 2022:89-112.
• Dixon DL, Harris IM, Aljadeed R, Anderson KC, Aycock A, Beavers C, Beckman EJ, et al. Overview of clinical practice guideline development, application to pharmacy practice, and roles for pharmacists. J Am Coll Clin Pharm 2023;6:73-84.
• Kenneally AM, Agbana P, Gardner B, Bae Y, Mitchell T, Beckman EJ. Compatibility of calcium chloride with milrinone, epinephrine, vasopressin, and heparin via in-vitro testing and simulated y-site administration. Am J Health Syst Pharm 2023;80:164-70.
• Kenneally AM, Behal ML, Beckman EJ, et al. Survey of critical care pharmacists on sedation and analgesia practices in adult and pediatric patients receiving continuous neuromuscular blocking agents. J Am Coll Clin Pharm 2022 Dec 22. [Epub ahead of print]
• Kleespies MS, Shah PA, Bondi DS. Use of calcitonin for hypercalcemia in a premature neonate with congenital mesoblastic nephroma. J Pediatr Pharmacol Ther 2022;27:682-6.
• Dittrich R, Melin K, Rowe JM. Stepping up to meet the needs of the LGBTQ community. J Am Pharm Assoc 2022;62:1458-62.
• Hovey S, Jacobson JL, Welsh KM, et al. Implementation of a pharmacist-driven vancomycin and aminoglycoside dosing service in a pediatric hospital. J Pediatr Pharmacol Ther 2022;27:340-6.
• Haftmann R, Pineda E, Hall B, et al. Comparison of time within therapeutic range using anti-factor Xa versus activated partial thromboplastin time monitoring of unfractionated heparin in children. J Pediatr Pharmacol Ther. [In press]
• Hovey SW, Arif SA, Khan AM, et al. More than a buzz word: building diversity, equity, and inclusion into pharmacy residency recruitment. J Am Coll Clin Pharm 2023;6:154-64.
• Feinstein JA, Feudtner C, Kempe A, Orth LE. Anticholinergic medications and parent-reported anticholinergic symptoms in neurologically impaired children. J Pain Symptom Manage 2023;65:e109-14.
• Feinstein JA, Orth LE. Making polypharmacy safer for children with medical complexity. J Pediatr 2023;254:4-10.
• Riedy M, Zhang JF, Huang T, et al. Infantile-onset Pompe disease with neutropenia: treatment decisions in the face of a unique phenotype. JIMD Rep 2023;64:17‐22.
• Galura G, Said SJ, Shah PA, Hissong AM, Chokshi NK, Fauman KR, Rose R, Bondi DS. Comparison of extracorporeal life support anticoagulation utilizing activated clotting time only to a multimodal approach in pediatric patients. J Pediatr Pharmacol Ther 2022;27:517-23.
• Hemmann B, Woods E, Makhlouf T, Gillette C, Perry C, Subramanian M, et al. Impact of patient-specific aminoglycoside monitoring for treatment of pediatric cystic fibrosis pulmonary exacerbations. J Pediatr Pharmacol Ther 2022;27:655-62.
• Patel P, Robinson PD, Wahib N, Cheung P, Wong T, Cabral S, Parker A, Cohen M, Devine K, Gibson P, Holdsworth MT, Neumann E, Orsey A, Phillips R, Spinelli D, Thackray J, et al. Interventions for the prevention of acute phase chemotherapy-induced nausea and vomiting and adult and pediatric patients: a systematic review and meta-analysis. Support Care Cancer 2022;30:8855-69.

 

Presentations

• Brent Hall: Which path is right for me? Pediatric residency training options: a panel discussion. Presented to: Students from the ACCP Pediatrics PRN and Pediatric Pharmacy Association; October 6, 2022; virtual.
• Ingrid Pan: Juvenile dermatomyositis – pediatric; systemic JIA – pediatric; and JIA – pediatric. Presented at: 2022 Rheumatology Advanced Practice Providers Conference; September 2022; Scottsdale, AZ.

 

New ACCP Fellows

• M. Brooke Bernhardt
• Nicholas M. Fusco

 

Other Notable Achievements

• Elizabeth J. Beckman:

Chair, Board of Pharmacy Specialties Pediatrics Specialty Council.

Chair-Elect, Society of Critical Care Medicine Clinical Pharmacy and Pharmacology Section Programming Committee.

Associate Editor, Comprehensive Critical Care: Pediatrics, Third Edition.

• Elizabeth Farrington: President, American College of Clinical Pharmacy.
• Brent Hall:

2022 AACP Preceptor of the Year Award.

Chair, Pediatric Pharmacy Association Core Competency Chair.

• Sarah Hovey:

PPA Executive Director Search Committee.

Section Lead for Research and Medication Safety Section, PPA Core Competencies.

• Joseph M. LaRochelle: Fellow, National Academies of Practice.
• Ingrid Pan: Program Director, 2023 ACCP Clinical Reasoning Series for Pediatric Pharmacy.

 

 

 

Awards

• Richard Parrish: Career Achievement Award, Clinical Administration PRN, American College of Clinical Pharmacy.

 

Publications

• Agnihotri G, Gross AE, Seok M, Yen CY, Khan F, Ebbitt LM, et al. Decreased hospital readmissions after programmatic strengthening of an outpatient parenteral antimicrobial therapy (OPAT) program. Antimicrob Steward Healthc Epidemiol 2023;3:e33.
• Levy BE, Castle JT, Ebbitt LM, et al. Opioid use after colorectal resection: identifying preoperative risk factors for postoperative use. J Surg Res 2023;283:296-304.
• Johnson EG, Weaver SG, Batt KL, et al. Low-dose adjuvant dexmedetomidine did not decrease propofol sedation requirements in children undergoing gastrointestinal endoscopy. Pharmacotherapy 2022;42:792-7.
• Olney WJ, Johnson EG, Potts C, et al. Continuing chronic buprenorphine perioperatively is associated with reduced postoperative opioid use. J Surg Res 2023;281:63-9.
• Bell CM, Procter LD, Parli SE. Asystole following concomitant intravenous administration of neostigmine and dexmedetomidine in a patient with acute colonic pseudo-obstruction. J Pharm Pract 2022;35:650-3.
• Buckman SA, Forrester JD, Bessoff KE, Parli SE, et al. Surgical Infection Society guidelines: 2022 updated guidelines for antibiotic use in open extremity fractures. Surg Infect (Larchmt) 2022;23:817-28.
• Parrish RH II, Bodenstab HM, Carneal D, Cassity RM, Dager WE, Hyland SJ, Lovely JK, et al. Positive patient postoperative outcomes with pharmacotherapy: a narrative review including perioperative-specialty pharmacist interviews. J Clin Med 2022;11:5628.
• Parrish RH II, Ciarkowski S, Aguero D, et al.; on behalf of the United States Pharmacopeia Compounded Drug Preparation Information Exchange Expert Panel. Creating data standards to support the electronic transmission of compounded nonsterile preparations (CNSPs): perspectives of a United States Pharmacopeia expert panel. Children 2022;9:1493.
• MacArthur RB, Ashworth LD, Zhan K, Parrish RH II. How compounding pharmacies fill critical gaps in pediatric drug development processes: suggested regulatory changes to meet future challenges. Children 2022;9:1885.

 

Presentations

• Laura Ebbitt: ERAS: what is it? How to do it. Presented at: Society of Critical Care Medicine Board Preparation; January 2023; San Francisco, CA.
• Sara Hyland and Richard Parrish: Optimal duration of anticoagulant venous thromboembolism prophylaxis after elective total joint arthroplasty. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.
• Richard Parrish:

Pharmacotherapy prophylaxis in elective colorectal surgery: preliminary results from a multi-site retrospective cohort study. Presented at: ERAS-USA 5th Annual Meeting; November 2022; Washington, DC.

Expanding pharmacotherapy data collection, analysis, and implementation in ERAS® programs for elective hepato-pancreato-biliary (HPB) surgeries: the methodology of a retrospective cohort study. Presented at: ERAS-USA 5th Annual Meeting; November 2022; Washington, DC.

Review of the ERAS pharmacological guidelines for visceral surgeries, B. Powers, H. Ponder. Presented at: ERAS-USA 5th Annual Meeting; November 2022; Washington, DC.

Pharmacotherapy prophylaxis in elective colorectal surgery: preliminary results from a multi-site retrospective cohort study. Presented at: Summer Student Research Poster Session, Mercer University School of Medicine; August 2022; Macon, GA.

Expanding pharmacotherapy data collection, analysis, and implementation in ERAS® programs. Presented at: Summer Student Research Poster Session, Mercer University School of Medicine; August 2022; Macon, GA.

Review of the ERAS pharmacological guidelines for visceral surgeries. Presented at: Summer Student Research Poster Session, Mercer University School of Medicine; August 2022; Macon, GA.

• William Vincent: Optimization of perioperative antimicrobial prophylaxis in surgical patients. Presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

 

New ACCP Fellows

• Jenna Lovely

 

 

 

Presentations

• Ashley Glode, Brian Faley, Elizabeth Santa, Hend Barry, Julianne Vanderhoogt-Davis, Marc Israel, Margaret Noyes Essex, Michael A. Kaminski, Raymond Pecini, Simon Tremblay, and Mark Shaefer. ACCP Pharmaceutical Industry PRN Pathways-to-Industry Career Roundtable Virtual Events; January 2023; virtual.

 

 

 

Promotions

• Aniwaa Owusu Obeng: Associate Professor, Department of Medicine, Icahn School of Medicine at Mount Sinai.

 

Awards

• Kelly Caudle:

Highly Cited Researcher 2022, Web of Science.

2023 Luminary Award, Precision Medicine World Conference.

• John Elliot Murphy III: Paul Parker Medal, ACCP.
• Aniwaa Owusu Obeng: Outstanding Young Alumni Award, Albany College of Pharmacy and Health Sciences.

 

Publications

• Eum S, Hill SK, Bishop JR. Considering medication exposure in genomic association studies of cognition in psychotic disorders. Pharmacogenomics 2022;23:791-806.
• Keshavan MS, Bishop DL, Coconcea C, Bishop JR. Clozapine, an update. Schizophr Res 2022;248:168-70.
• Brown JT, Beery N, Taran A, et al. Associations between CES1 variants and dosing and adverse effects in children taking methylphenidate. Front Pediatr 2023;10:958622.
• Brown JT, McGonagle E, Seifert R, Speedie M, Jacobson PA. Addressing disparities in pharmacogenomics through rural and underserved workforce education. Front Genet 2023;13:1082985.
• Butler T, Brown JT, Jacobson P, et al. Perceptions of pharmacogenetic exceptionalism and the implications for clinical management within an electronic health record. Clin Transl Sci 2022;15:2265-74.
• Van Hooser J, Swanson S, Conway JM, Brown JT. Assessing pharmacy students baseline burnout, stress, quality of life, empathy, and tolerance for ambiguity. Curr Pharm Teach Learn 2022;14:966-71.
• Lumish M, Thackray J, Kinh Gian Do R, Caudle KE, et al. Precision management of a patient with dihydropyrimidine dehydrogenase deficiency and liver predominant metastatic rectal cancer utilizing hepatic arterial floxuridine. JCP Precis Oncol 2023;7:e2200442.
• Steiner HE, Carrion KC, Giles JB, Lima AR, Yee K, Sun X, Cavallari L, Perera M, Duconge J, Karnes JH. Local ancestry-informed candidate pathway analysis of warfarin stable dose in Latino populations. Clin Pharmacol Ther 2022. [In press]
• France K, Ammend D, Brown JT. Sertraline trough concentrations in children stratified by CYP2C19 genotype at a residential treatment center: a pilot study. Innov Pharm 2022;13:Article 15.
• Gammal RS, Pirmohamed M, Somogyi AA, Morris SA, Formea CM, Elchynski AL, Oshikoya KA, McLeod HL, Haidar CE, Whirl-Carrillo M, Klein TE, Caudle KE, et al. Expanded Clinical Pharmacogenetics Implementation Consortium guideline for medication use in the context of G6PD genotype. Clin Pharmacol Ther 2022 Sep 1. [Epub ahead of print]
• Magarbeh L, Hassel C, Choi M, Islam F, Marshe V, Zai CC, Zuberi R, Gammal RS, et al. ABCB1 gene variants and antidepressant treatment outcomes: a systematic review and meta-analysis including results from the CAN-BIND-1 study. Clin Pharmacol Ther 2023 Jan 22. [Epub ahead of print]
• Haidar CE, Crews KR, Hoffman JM, Relling MV, Caudle KE. Advancing pharmacogenomics from single-gene to preemptive testing. Annu Rev Genomics Hum Genet 2022;23:449-73.
• Kehr AM, Ayers G, Saxena S, Hashmi AZ, Erwin AL, Azene A, Hockings JK. Integration of a pharmacist-led pharmacogenomic service in a geriatric clinic: barriers and outcomes. J Am Pharm Assoc (2003) 2023 Jan 7. [Epub ahead of print]
• Louis S, Busch RM, Lal D, Hockings J, et al. Genetic and molecular features of seizure-freedom following surgical resections for focal epilepsy: a pilot study. Front Neurol 2022;13:942643.
• Sharma A, Johnson KB, Bie B, Rhoades EE, Sen A, Kida Y, Hockings J, et al. A multimodal approach to discover biomarkers for taxane-induced peripheral neuropathy (TIPN): a study protocol. Technol Cancer Res Treat 2022;21:15330338221127169.
• Wu BP, Wheeler M, Hockings JK, et al. Altered mental status in a man with metabolic syndrome. Cleve Clin J Med 2022;89:445-50.
• Wen YF, Jacobson PA, Oetting WS, Pereira C, Brown JT. Knowledge and attitudes of incoming pharmacy students toward pharmacogenomics and survey reliability. Pharmacogenomics 2022;23:873-85.
• Feng J, Astiazaran-Symonds E, Karnes JH. Visualization and quantification of the association between breast cancer and cholesterol in the All of Us Research Program. Cancer Inform 2022;22:11769351221144132.
• Sangam S, Sun X, Schwantes-An TH, Yegambaram M, Lu Q, Zagorski J, Morrisroe SA, Shi Y, Cook T, Fisher A, Frump AL, Coleman A, Sun Y, Liang S, Crawford H, Lutz KA, Maun AD, Pauciulo MW, Karnes JH, et al. SOX17 deficiency mediates pulmonary hypertension: at the crossroads of sex, metabolism, and genetics. Am J Respir Crit Care Med 2023. [In press]
• Massmann A, Heukelom JV, Larson C, et al. Leveraging clinical decision support to reduce the risk of discordant pharmacogenomics results. Pharmacogenomics 2022;23:987-93.
• Baye J, Massmann A, Petry N, et al. Development and early evaluation of clinical decision support for long QT syndrome population screening. J Transl Genet Genom 2022;6:375-87.
• Murphy JE, ed. Clinical Pharmacokinetics, Seventh Edition. American Society of Health-System Pharmacists, 2022.
• Murphy JE. Clinical Pharmacokinetics Workbook, Seventh Edition (companion product to Clinical Pharmacokinetics, Seventh Edition). American Society of Health-System Pharmacists, 2022.
• Abdelhalim SM, Murphy JE, Meabed MH, et al. Comparative effectiveness of adding omega-3 or vitamin D to standard therapy in preventing and treating episodes of painful crisis in pediatric sickle cell patients. Eur Rev Med Pharmacol Sci 2022;26:5043-52.
• Obeng AO, Scott SA, Kaszemacher T, et al. Prescriber adoption of SLCO1B1 genotype-guided simvastatin clinical decision support in a clinical pharmacogenetics program. Clin Pharmacol Ther 2023;113:321-7.
• Pasternak AL, Ward K, Irwin M, Okerberg C, Hayes D, Fritsche L, Zoellner S, Virzi J, Choe HM, Ellingrod V. Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation services. Clin Transl Sci 2023;16:292-304.
• Shugg T, Powell NR, Marroum PJ, et al. Evaluation of US Food and Drug Administration drug label recommendations for coadministration of antivirals and acid-reducing agents. Clin Pharmacol Ther 2022;112:1088-97.
• Rowe EJ, Shugg T, Ly RC, et al. Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer. Front Cardiovasc Med 2022;9:894623.
• Smith DM, Figg WD. Evidence regarding pharmacogenetics in pain management and cancer. Oncologist 2023 Jan 30. [Epub ahead of print]
• Smith DM, Wake DT, Dunnenberger HM. Pharmacogenomic clinical decision support: a scoping review. Clin Pharmacol Ther 2023;113:803-15.
• Socco S, Wake DT, Lee JC, Dunnenberger HM. Pharmacogenomics of medications given via nonconventional administration routes: a scoping review. Pharmacogenomics 2022;23:933-48.
• Zhang L, Jacobson PA, Johnson ANK, Gregornik DB, Johnson SG, McCarty CA, Bishop JR. Public attitudes toward pharmacogenomic testing and establishing a statewide pharmacogenomics database in the state of Minnesota. J Pers Med 2022;12:1615.
• Allen JD, Zhang L, Johnson ANK, Jacobson PA, McCarty CA, Pittenger AL, Bishop JR. Development and validation of the Minnesota Assessment of Pharmacogenomic Literacy (MAPL). J Pers Med 2022;12:1398.

 

Grants

• Jason Karnes: Administrative Supplement to Advance Precision Medicine Using the All of Us Research Program’s Data: R01 HL158686. NIH/National Heart, Lung, and Blood Institute. Principal Investigator.
• Tyler Shugg: Investigation of the Immune-Mediated Drug-Drug Interaction Potential of Immune Checkpoint Inhibitors. Principal Investigator ($863,315).

 

Other Notable Achievements

• Tyler Shugg: Diplomate, American Board of Clinical Pharmacology for “Applied Pharmacology.”

 

 

 

Promotions and New Positions

• Megan Fleischman: Started a new position as an Assistant Professor of Pharmacy Practice, Concordia University of Wisconsin.
• Brooke Foster: Started a new position as an Ambulatory Care Clinical Pharmacist, Pulmonary Clinic – Froedtert Health.
• Julio A. Rebolledo: Started a new position as Clinical Assistant Professor, University of Illinois Chicago College of Pharmacy, and will be starting a new diabetes telemedicine clinic.

 

Awards, Honors, and Recognition

• Paul Boylan:

Teaching and Mentoring Award, ACCP Education and Training PRN.

2022 Outstanding Educator, The University of Oklahoma Health Sciences Center College of Pharmacy Department of Pharmacy.

Top Poster Award, ACCP Education and Training PRN.

Top Poster Award. ACCP Adult Medicine PRN.

• Megan Fleischman: Achieved Level IV pharmacist status at Froedtert Health.
• Desiree Kosmisky: Fellow, American College of Critical Care Medicine.
• Paul Solinsky: 2023 Minogue Award for Patient Safety Innovation, Maryland Patient Safety Center, for implementation of the AIR-COPD model (Acute Interdisciplinary Response to COPD) at Baltimore Washington Medical Center.

 

Publications

• Foster B, Obidare-Kolade D, Nagy M. Assessment of primary care provider and pharmacist knowledge, comfort, and barriers to appropriate inhaled corticosteroid use in chronic obstructive pulmonary disease. J Am Coll Clin Pharm 2023 Jan 2. [Epub ahead of print]
• Bakken BK, Bozymski KM, Foster B, et al. Ambulatory care pharmacy practice: findings from the 2019 National Pharmacist Workforce Survey. Am J Health Syst Pharm 2023;80:284-95.
• Lim L, Lipari M, Kale-Pradhan P. Intranasal olopatadine: mometasone in the treatment of seasonal allergic rhinitis. Ann Pharmacother 2022 Sep 19. [Epub ahead of print]
• Hudson JQ, Maxson R, Barreto EF, Cho K, Condon AJ, Goswami E, Moon J, et al. Education standards for pharmacists providing comprehensive medication management in outpatient nephrology settings. Kidney Med 2022;4:100508.
• Montag Schafer K, Harris I, Lounsbery JL, Philbrick A, Moon J. Shifts in pharmacists’ responsibilities in family medicine residency programs during COVID-19. Innov Pharm 2022;13:10.24926/iip.v13i1.4559.
• Nissly T, Moon JY, Ricco J. Asthma management: how the guidelines compare. J Fam Pract 2022;71:392-7.
• Santibañez M, Maldonado A, Hawkins Smith C, et al. 57: Building blocks for implementing a multi-site resident research certificate program: a pilot study. J Am Coll Clin Pharm 2022;5:1369.
• Acquisto NM, Buckley M, Adams C, Ammar M, Brandt K, Bullard H, Choron R, Chudow M, Deshpande R, Fontaine G, Johansson M, Jontz A, Musselman M, O’Connor M, Rodricks M, Santibañez M, et al. 12: Critical care pharmacy practice advancement recommendations on direct patient care activities: a Delphi study [abstract]. J Am Coll Clin Pharm 2022;5:1367.
• Robainas M, Maldonado A, Santibañez M, et al. 776: Fixed versus variable prothrombin complex concentrate dosing protocol for warfarin-related bleeding [abstract]. Crit Care Med 2023;51:379.
• Rzasa K, Santibañez M, Smedley L. Benzodiazepine alternatives for agitation in palliative care. SCCM Clinical Pharmacy and Pharmacology Section Newsletter 2022;22:14-8.

 

Presentations

• Paul Boylan:

Updates on allergic rhinitis and conjunctivitis: when to recommend the new Rx-to-OTC switches. Presented at: Walter P. Scheffe Continuing Pharmaceutical Education Series; October 2022; Oklahoma City, OK.

Building a better tomorrow with your colleges of pharmacy. Presented at: National Association of Boards of Pharmacy Districts 6, 7, 8 Meeting; August 2022, Oklahoma City, OK.

• Brooke Foster

Aging – hypertension, hyperlipidemia and osteoporosis. Presented at: 2022 North American Cystic Fibrosis Conference; November 2022; Philadelphia, PA.

Cystic fibrosis new therapies: do they help digestive function? Presented at: John F. Gilmore, Jr. Symposium for Excellence in Nutrition Enteral Feedings; September 2022; Chicago, IL.

• Julio A. Rebolledo: Health disparities in asthma among Hispanics, Latinos and Blacks. Presented at: Association of Asthma Educators Annual Conference; August 2022; Chattanooga, TN.
• Melissa Santibañez:

Curbing constipation-centered concerns. Platform presentation for the Treatments on Autopilot session during SCCM Critical Care Congress; January 2023; San Francisco, CA.

Fixed versus variable prothrombin complex concentrate dosing protocol for warfarin-related bleeding. Research snapshot presented at: SCCM Critical Care Congress; January 2023; San Francisco, CA.

Evaluation of outcomes after implementation of a hyponatremia management order set in an acute care facility. Research-in-progress poster presented at: ASHP Midyear Clinical Meeting; December 2022; Las Vegas, NV.

Building blocks for implementing a multi-site resident research certificate program: a pilot study. Poster presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

Critical care pharmacy practice advancement recommendations on direct patient care activities: a Delphi study. Poster presented at: 2022 American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; October 2022; San Francisco, CA.

Surviving the new sepsis guidelines. Presented at: FSHP Annual Meeting’s critical care track; August 2022; Orlando, FL.

Roles of a preceptor workshop. Virtual presentation for Memorial Healthcare System inaugural preceptor development series; August 2022; virtual.

 

 

 

Awards

• Sally Rafie: Vital Contributions to Women’s Health Award, ACCP Women’s Health PRN.

 

Grants

• Sally Rafie, Ashley Meredith, and Jenny Newlon: Hormonal Contraceptive Access via Pharmacist-Prescribing Implementation Package (HAPPI). CDC Research Award.

 

Presentations

• Jaini Patel: Preeclampsia and eclampsia: treatment and prevention. Presented at: Midwestern University’s Chicago College of Osteopathic Medicine Grand Rounds; January 2023; Downers Grove, IL.

 

Publications

• Cieri-Hutcherson NE, Lomakina A, Chilbert MR. Retrospective study of appropriate primary prevention in postmenopausal women presenting with a major adverse cardiovascular endpoint (MACE). Pharmacy (Basel) 2022;10:105.
• Cieri-Hutcherson NE, Vernon V. Interactive case: menopause. In: Sanoski CA, Witt DM, eds. Pharmacotherapy Self-Assessment Program, 2023 Book 1. Endocrinology and Nephrology. American College of Clinical Pharmacy, 2023:163-9.
• Hutcherson TC, Cieri-Hutcherson NE, Lycouras MM, et al. Systematic review of evening primrose oil for labor induction. Pharmacy (Basel) 2022;10:172.
• Cirrincione LR, Nakalema S, Chappell CA, Byakika-Kibwika P, Kyohairwe I, Winchester L, Mackline H, Pham MM, Cohn SE, Siccardi M, Owen A, Fletcher CV, O’Grady N, Davis M, McManus D, et al. Dosing implications for liposomal amphotericin B in pregnancy. Pharmacotherapy 2023 Mar 2. [Epub ahead of print]
• Chang F, O’Connell MB, Mills ME, et al. Preventive health therapy and behavior outcomes from a brown bag medication review for ambulatory older adults. J Am Geriatr Soc 2022;70:3202-9.
• Pellacio K, Bright D, Dillaway H, O’Connell MB. Birth control use and access including pharmacist-prescribed contraception services during COVID-19. Pharmacy 2022;10:142.
• Rashid Z, O’Connell MB, Yang K. Implementation issues with pharmacist prescribed contraception in Michigan community pharmacies using the transtheoretical domain framework. J Am Coll Clin Pharm 22;5:1253-62.
• Rafie S, Kaller S, Ma M, et al. “No big deal”: a qualitative study of pharmacists’ perspectives on dispensing mifepristone for medication abortion. Womens Health Issues 2022;32:571-7.
• Lamorde M, Scarsi KK. Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: the DoubLNG pharmacokinetic study. Contraception 2023 Feb 12. [Epub ahead of print]
• Vernon V, Patel J, Cieri-Hutcherson NE, Arellano R, Elmore H, Griffin B, Mitzel K, Moyeno WM, O’Connell MB, Pelaccio K, Lodise N. The impact of COVID-19 on select considerations in patients of reproductive age: brief talking points for pharmacists. J Am Pharm Assoc 2023 Jan 11. [Epub ahead of print]